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Abstract
Title: Perceptions of Naloxone Training and Administration Among Law Enforcement
Officers
Author: Katelyn Rae Goodall, M.S., M.A.
Major Advisor: Vida Tyc, Ph.D.
The opioid epidemic was officially declared a public health emergency in 2017
when the rate of deaths per day from opioid overdoses was steadily increasing (CMS,
n.d.). As of 2019 – 2020, 61,297 of the 83,544 reported drug overdose deaths were
attributed to opioids in general, with 48,729 accounted for by synthetic opioids (CDC,
2021). Due to the significant impact on public health and safety, law enforcement
departments have been tasked with developing and implementing naloxone policies and
trainings. Law enforcement officers are often the first on the scene of an overdose
outnumber fire rescue and emergency medical responders across much of the United
States (Lurigio et al., 2018). Equipping officers with naloxone affords the opportunity to
administer life-saving interventions as a means of combating the opioid epidemic.
In a review of the types of harm reduction trainings developed for law
enforcement, Khorasheh et al. (2019) found that there were varied formats of delivery,
duration, content, location of delivery, and the developer/facilitator of trainings. No
study to date has assessed the impact of individual components of training and the role of
the facilitator at enhancing the transfer of training, specifically related to naloxone
training. This study evaluated training components from a transfer of training model. The
current study examined responses from 82 law enforcement officers in agencies across
the United States via a survey designed to assess officer perceptions of substance users,
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naloxone training, effectiveness of training, and preparedness to respond to opioid
overdose calls. The results of this study indicated perceived agency priority on naloxone
training and officer’s perception of training as relevant to their career both significantly
impacted overall perception of naloxone training effectiveness.
Keywords: naloxone, naloxone training, transfer of training, opioid, opioid
epidemic, law enforcement, police, public safety
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Chapter 1: Introduction
In 2017, President Donald Trump declared the ongoing issues related to opioid
mortality and morbidity a public health crisis (CMS, n.d.). Opiates are a class of drugs
derived from the opium poppy plant known to produce a pain-relieving effect in the brain
(Boyer, 2012; Butanis, 2018). Opioids can be formulated into analgesic pills to treat
moderate to severe chronic pain and certain psychiatric disorders. Opioids are also the
core components of many illicit drugs, such as heroin and fentanyl. Opioids work by
attaching to receptors in the brain and throughout the body to create a relaxing effect.
Specific opioid receptors in the brain stem are also responsible for modulating respiratory
responses (Boyer, 2012). This means that opioids can slow or stop respiration all-together
if taken at too high a dosage.
One of the biggest impacts on the opioid crisis was the establishment of pain
clinics. Colloquially referred to as “pill mills”, pain clinics initially had very little
oversight and regulation from the federal and state governments (Delcher et al., 2015;
Kennedy-Hendricks et al., 2016; Philip, 2018; Spencer, 2019). This lack of oversight
allowed pain clinics, specifically in the state of Florida, to become the primary distributor
of the United States’ opioid prescriptions (Johnson et al., 2014; Kennedy-Hendricks et
al., 2016). The increase in opioid prescriptions lead to an increase in opioid related
overdoses and deaths. Moreover, law enforcement was not prepared in how to combat
legally prescribed opioids in the context of the growing opioid crisis. There existed no
precedent in how law enforcement should combat a problem that has no legal regulations
or oversight, though contributes to a growing number of substance abuse overdoses and
enhanced the growing opioid epidemic.
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Many rural areas, and even urban areas, work to combat the overwhelming
amount of opioid related overdoses and deaths utilizing law enforcement officers as
medical first responders. In much of the United States, law enforcement officers
outnumber fire rescue and emergency medical responders (Lurigio et al., 2018). They are
also often first to arrive on the scene of an overdose, positioning them in a unique role to
offer live-saving interventions. This has demonstrated an enhanced need for law
enforcement officers to play a more vital role as medical first responders in the context of
the opioid crisis.
There is a general understanding that the role of a law enforcement officer is to
enhance public safety and preserve quality of life for citizens. In the last decade, an
officer’s role has been expanded through legislation targeted to combat the opioid
epidemic. This has shifted the role of an officer to include substance abuse intervention
and emergency life-saving treatment, which has placed an additional emphasis on the
training of law enforcement officers to recognize signs of an opioid overdose. This can
include the discrimination between an overdose, opioid toxicity, and other medical
conditions, as well as proper administration of emergency opioid antagonists such as
naloxone. The following literature review will examine a review of factors proposed to
have resulted in this increased contact between law enforcement and opioid users.
Discussion will also be centered around new diversion trends to combat increasing
incidences of mortality and morbidity associated with opioid overdoses, a review of
Naloxone training, and available research and current limitations of Naloxone training
effectiveness.
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Chapter 2: Literature Review
Opioids
Typically, the Centers for Disease Control and Prevention (CDC) classify opioids
as either natural, semi-synthetic, or methadone (2020b). Natural opioids include opioid
analgesics such as morphine and codeine. Semi-synthetic opioids refer to prescription
pain medications including “oxycodone, hydrocodone, hydromorphone, and
oxymorphone” (CDC, p. 1, 2020b). Methadone is classified separately from other opioids
and is typically prescribed either as a form of chronic pain management or for the
treatment of opioid use disorders.
Across the United States, there has been increasing morbidity and mortality
associated with opioid overdoses. From 2002 - 2010, there was a substantial increase in
the overall amount of prescription opioids issued and opioid related overdoses (Dart et
al., 2015). This trend appeared to plateau from 2011 to 2013, likely as a result of federal
and state legislation and targeted opioid abuse interventions (Dart et al., 2015; Compton,
Boyle, & Wargo, 2015). There was an inverse relationship noted between heroin-related
overdoses and opioid-related overdoses. Targeted interventions to combat the opioid
epidemic included educational initiatives, prescriber education, Prescription Drug
Monitoring Programs (PDMP), law enforcement initiatives, Opioid Overdose Prevention
Programs (OOPP), and increased access to Medication Assisted Treatments (MAT) and
naloxone (Compton, Boyle, & Wargo, 2015; Compton et al., 2016).
The CDC (2021) released statistical data related to the overall incidence of drug
overdoses across the United States annually from January 2015 - July 2020. In January of
2015, there were 47,523 overdose deaths reported within the previous year and 83,544
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overdose deaths reported from July 2019 to July 2020 demonstrating an upward trend in
total drug overdose deaths. Of the 83,544 reported drug overdose deaths between July
2019 - July 2020, 61,297 were attributed to opioids in general, with 48,729 accounted for
by synthetic opioids (CDC, 2021).
In 2018, the CDC (2020b) reported that approximately 40 people, on average,
were dying daily due to overdoses associated with prescription opioids, accounting for
32% of all opioid-related mortalities. Mortality associated with opioid overdoses in the
state of Florida for 2018 accounted for 68% (3,189) of all drug overdose deaths (National
Institute on Drug Abuse, 2020a). The majority of deaths (2,091) were attributable to
synthetic opioids, fentanyl and fentanyl analogs. In Florida from October 2019 - June
2020, there were over 5,000 deaths attributable to opioids, with over 4,000 opioid related
overdoses attributable to synthetic opioids.
In response to the increasing mortality associated with opioid overdoses, a
number of initiatives were undertaken by law enforcement to combat the opioid
epidemic. Controversial for negative perceptions associated with its use, naloxone
training has been one of the universal initiatives undertaken by many departments. As
law enforcement officers are typically the first to respond to a suspected opioid overdose,
many agencies have developed policies and trainings focusing on the emergency
intervention of naloxone administration for the reversal of opioid overdose.
Prescription Opioid Crisis
In 1970, the United States passed legislation collectively referred to as the
Controlled Substances Act (Drug Enforcement Agency, n.d.; U.S. Department of Justice,
2016; U.S. Department of Justice, 2018). The core intention of the act was to provide
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guidelines for placement of substances in one of five schedules. This classification of a
substance was determined by three key factors: “the substance’s medical use, potential
for abuse, and safety or dependence liability” (Drug Enforcement Agency, n.d.). Under
the Controlled Substances Act, a substance may be initially added or transferred to a
higher or lower schedule (controlled) or removed from the schedule for control
(decontrolled).
The trends in prescribing opioids within the medical communities in the U.S.
were disparate from 2007 to 2012 (Levy et al., 2015). Almost half of all opioid
prescriptions were generated by primary care practitioners, equaling roughly half of the
controlled substance prescriptions for opioids across the U.S. At this rate, the primary
care prescribers were prescribing opioids beyond the rise in prescribing of all prescription
medications. This trend, however, came to an end in 2010. In a 2014 survey of primary
care providers, Jamison et al. (2014) found that younger providers experienced higher
levels of stress and felt greater reluctance to prescribe opioids when treating patients with
chronic pain as compared to older providers. Further, they reported less overall
confidence in pain management and were more concerned about the potential for opioid
dependence than more senior providers (Jamison et al., 2014).
In 2017, the Network for Public Health Law reported that across the United
States, drug overdoses were responsible for the deaths of nearly 72,000 people (Davis,
2018). Of the 72,000 reported deaths in 2017, opioids such as prescription painkillers,
heroin, and fentanyl are responsible for an estimated 49,000 fatalities or a total of 67% of
mortalities (Strickler, Kreiner, Halpin, Doyle, & Paulozzi, 2020). The number of annual
drug overdoses decreased to 67,000 in 2018; however, opioid-related overdoses
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accounted for approximately 70% of the total drug overdoses in 2018, representing a
slight increase from the 68% of total opioid-related overdoses in 2017. Additionally,
estimates as of 2018 indicate that prescription opioids, Oxycontin and hydrocodone, are
now accountable for more overdose-related deaths annually than heroin and cocaine
combined.
In Florida specifically, prescription opioid related deaths decreased between 2017
and 2018. The annual drug report released by the Medical Examiners Commission for
2018 indicated that benzodiazepine related deaths from prescription drugs such as
Alprazolam, Clonazepam, and Diazepam declined by 12.4%, 4.6%, and 10.9%,
respectively (Nelson et al., 2019). In an opposing trend, fentanyl-related deaths increased
by 29.5%. The reported manner of death related to benzodiazepines and opioids is
overwhelmingly accidental (i.e., Alprazolam 67%, Diazepam 53%, Fentanyl 93% Heroin
95.6). The 2019 report showed an overall decrease across most benzodiazepines and
prescription drug-related deaths (Nelson et al., 2020). Fentanyl and fentanyl analogs
represented 35.2% and 34.8% increases, respectively, of deaths related to overdose for
these particular opioids. Of these fentanyl and fentanyl analog associated deaths, the
manner of death was recorded as accidental in 93% and 97.2% of cases, respectively.
General Response
In 2008, the United States Conference of Mayors issued a resolution in
conjunction with other major organizations (i.e., the American Medical Association
(AMA), the American Public Health Association (APHA), and the National Association
of Boards of Pharmacy (NABP), urging states to remove barriers to the public’s ability to
attain emergency medical assistance and administration of naloxone in the event of a
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substance-induced medical crisis (Davis, 2018). Many states adopted general policies
reducing the legal obstacles inhibiting the availability of naloxone from being prescribed
to persons other than the individual at risk for potential overdose. Moreover, many states
also removed the limitation of an individual needing to attend an appointment with a
prescriber before receiving a prescription for naloxone. Legislation granting access to
naloxone by individuals who are not at risk has been approved by 50 states, as well as the
District of Columbia, as of 2017. In the general public, this measure has decreased
opioid-related overdose mortality rates by an average of 14%; approximately 23% of
opioid-related deaths in the African American population.
Education
In 2016, the White House made a public plea for medical schools in the United
States to agree to expand the training related to opioid prescribing based on the CDC
guidelines (Karon, 2017). Following this address issued by the White House, the AMA
established the Opioid Task Force to create guidelines for enhancing training in medical
school programs related to opioid prescribing and best practices (American Medical
Association, 2020). In 2018, more than 700,000 physicians and other healthcare
professionals completed continuing medical education training and accessed other
educational resources provided by the AMA and other state and specialty medical
associations. These trainings included information related to opioid prescribing, pain
management, and screening for substance use disorders.
Additionally, the AMA (2020) identified the need for comprehensive treatment of
substance use disorders, including the co-prescribing of naloxone to patients at risk of
overdose. This action can decrease instances of controlled substance-related overdoses
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and has additionally led to a significant increase in the prescribing of Naloxone. In 2019,
there were over 1 million reported prescriptions for Naloxone, which represents a
substantial increase from the 6,588 prescriptions issued in 2015 (American Medical
Association, 2020). Medical societies have helped nearly every state implement enhanced
naloxone access laws for pharmacists, physicians, emergency responders, and mental
health care workers (American Medical Association, 2020; Philip, 2018).
SAMHSA Strategic Plan.
Substance Abuse and Mental Health Services Administration (SAMHSA) has
also rallied in response to the opioid crisis and created a multi-tiered strategic plan
outlining actionable items to be addressed between 2019 and 2023 fiscal years (Substance
Abuse and Mental Health Services Administration, 2019). A total of five priority areas
are included in the strategic plan, one of which is reducing opioid misuse, use disorder,
overdose, and related health consequences, through the implementation of high quality,
evidence-based prevention, treatment, and recovery support service. Measurable
objectives related to this goal are to advance the practice of pain management by
promoting technical assistance, training, and effective educational strategies to clinicians,
policymakers, and the public on the risks of opioid pain medications, and to support the
dissemination and adoption of evidence-based guidelines for acute and chronic pain
management in both general and high-risk populations to mitigate the risk of opioid
misuse, use disorders, and overdose (Substance Abuse and Mental Health Services
Administration, 2019).
The CDC (2019) also responded to concerns of healthcare providers related to a
lack of training in pain management, as well as the increased concerns regarding patient
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risk of opioid addiction and overdose. The CDC created the “CDC Guidelines For
Prescribing Opioids for Chronic Pain” (2019) in 2016. This program allows prescribers
access to recommendations regarding opioid prescribing practices. The CDC also created
a continuing education interactive series for training that provides education related to the
CDC guidelines on opioid prescribing (Centers for Disease Control, 2019).
Another priority area outlined in the strategic plan includes enhancing and
strengthening healthcare practitioner education and training (Substance Abuse and
Mental Health Services Administration, 2019). This includes objectives such as
developing and disseminating clinical practice guidelines to healthcare professionals on
evidence-based treatment of co-occurring substance use, mental disorders, and pain
disorders. Additionally, substance use education should include core training elements
disseminated to colleges, universities, and health professional schools, and SAMHSA’s
Regional Offices.
Florida Medical Schools.
The Council of Florida Medical School Deans created a Pain Management
Workgroup in 2018 to develop a framework ensuring medical students are provided with
education and training related to the most up-to-date information, as well as pain and
addiction treatment best-practices (Council of Florida Medical School Deans, 2018;
Philip, 2018). Within this framework are guiding principles outlining core competencies
to be addressed in four domains relevant to the student’s level of training and stage of
education. Also discussed within this framework is the guidance for executing and
implementing the core competencies within medical school training programs.

PERCEPTIONS OF NALOXONE TRAINING

10

Furthermore, the Council of Florida Medical School Deans included the process for
evaluating student competencies in core areas related to pain and addiction treatment.
Good Samaritan Law
Good Samaritan laws originally were implemented to protect bystanders, not
including law enforcement or medical professionals operating while on the job, who
intervene in an emergency situation from legal repercussions. Another step taken by the
states in response to the previously adopted resolutions by the United States Conference
of Mayors included amendments made to current Good Samaritan laws (Davis, 2018).
These changes included removing the legal ramifications and punitive penalties for
bystanders who call emergency responders during a drug overdose (Florida Behavioral
Health Association, 2017). These modifications mean that bystanders could no longer be
arrested or face other consequences should they call 911 while witnessing a drug
overdose. In 2018, 46 states and the District of Columbia had passed amendments to the
Good Samaritan law offering some safeguards from prosecution for reported drug
overdoses by bystanders. Across the United States, the amendments to the Good
Samaritan laws have been associated with a 15% decrease in opioid-related overdose
deaths and a 26% decrease in opioid-related deaths among African Americans (Davis,
2018).
Prescribing Changes and Monitoring Programs
The immediate need for prescription regulation became apparent as a result of the
declaration of the opioid epidemic in 2017 and required national and professional
attention from qualified prescribers. The Prescription Behavior Surveillance System
(PBSS) has been in operation since 2011 and was the initial system of its kind used to
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track the prescribing of controlled substances (Philip, 2018). While the PBSS was
moderately effective, the CDC recognized the need for revitalizing the approach to
monitoring controlled substance prescribing and the creation of a new tracking system
due to the rapid increase of opioid-related overdoses. Specifically, the CDC addressed the
need for more stringent and clearer guidelines related to opioid prescribing (Centers for
Disease Control, 2019).
Enhanced prescription monitoring programs were developed in response to the
gaps in the PBSS. The Prescription Drug Monitoring Programs (PDMP) are state level
initiatives developed to track opioid prescribing to reduce the potential for
overprescribing and abuse (Ponnapalli et al., 2018). Overall, electronic PDMPs across the
United States were associated with reductions in opioid related overdoses and changes in
opioid prescribing (Ponnapalli et al., 2018; Cerdá et al., 2020).
This resulted in CDC personnel preparing policies that specifically address the
initiation or continuation of prescription opioids for chronic pain, selection of the
appropriate prescription opioid, correct dosage, length of prescription, period of time for
follow-up, and discontinuation of opioid therapy (Dowell, Haegerich, and Chou, 2016).
The authors further noted the CDC provided instructions for how to assess risk and the
potential risks of opioid use. Although these guidelines were created to improve bestpractices in prescribing, they also served to enhance communication between clinicians
and patients regarding both the potentially harmful effects and advantages of opioid
therapy. These CDC guidelines were initiated due to the concern that many clients being
prescribed opioids were not fully aware of the risks and benefits associated with opioid
therapy. The CDC guidelines also proposed alternative initial treatment modalities for
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chronic pain be discussed with the client that are non-opioid treatments. This was met
with many barriers from insurance companies, the majority of whom do not provide
coverage for alternative non-opioid therapies geared towards chronic non-malignant pain
management (i.e., therapeutic massage, acupuncture) (Philip, 2018).
Prescription Drug Monitoring Program.
Created in 2009 by the Florida legislature, the Prescription Drug Monitoring
Program, also referred to as the Electronic-Florida Online Reporting of Controlled
Substance Evaluation Program (E-FORCSE), was established with the intention of
encouraging more cautious and conservative prescribing of controlled substances and to
decrease the potential for abusing prescription medications (Florida Behavioral Health
Association, 2017; Florida Department of Health, 2020; Florida Department of Health,
2021b; SB 440, 2009). Providers and dispensers (i.e., pharmacists) who have a Drug
Enforcement Administration (DEA) registration for prescribing or dispensing controlled
substances register for access on the Prescription Drug Monitoring Program website.
After registering, providers and dispensers are able to access the Prescription Drug
Monitoring Program and document prescriptions, and view schedule II, III, IV, and V
substances an individual has been prescribed by other physicians or that have been
dispensed by pharmacists.
Section 893.03 of the Prescription Drug Monitoring Program dictates that the
program must be accessed by a physician prior to prescribing any schedule II, III, IV, and
V controlled substances in order to review their patient’s prescribing history (Florida
Department of Health, 2021b). It further clarifies that the Prescription Drug Monitoring
Program must be consulted any time a prescription is written or filled for a patient, not

PERCEPTIONS OF NALOXONE TRAINING

13

just on the initial visit or prescription dispensed to the patient. The physician or dispenser
must then enter the prescription information into the Prescription Drug Monitoring
Program by the end of business the following day. The failure to report prescribing or
dispensing of schedule II, III, IV, and V controlled substances results in an initial nondisciplinary citation with subsequent offenses producing punitive action against the
prescriber or dispenser’s license (Florida Department of Health, 2021b). As a result of the
implementation of this tracking and monitoring system, there was a 4.6 percent decline in
prescribing controlled substances in the state of Florida between 2017 - 2018, resulting in
a total of 33,024,567 total opioid prescriptions (Philip, 2018).
Enhanced State Opioid Overdose Surveillance
Another actionable step that expanded the collection, monitoring, and release of
data related to fatal and non-fatal opioid overdose data, concerned the CDC’s
dissemination of funding for the Enhanced State Opioid Overdose Surveillance
(ESOOS). In 2016, Florida was awarded funds for the purpose of enhancing its ability to
track opioid-related overdoses. This was accomplished by accelerating the time in which
both fatal and non-fatal overdoses are reported as a means of increasing prevention and
emergency response capabilities for opioid-related overdoses (Centers for Disease
Control and Prevention, 2020). This effectively created an early warning system to alert
agencies of increases in fatal or non-fatal opioid-related overdoses, which allowed for the
systematic integration of trends within and across states to detect trends in order to
enhance preventative measures.
In addition to reporting general information related to opioid overdoses, the
ESOOS also sends data related to whether or not Naloxone is administered during an
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Emergency Medical Service (EMS) transport or not, and if so, how many doses were
given (Centers for Disease Control and Prevention, 2020a). Another aspect of reporting
includes the toxicology reports of fatal overdoses to monitor the increasing issue of
fentanyl and fentanyl analogs. As a result of this aspect of monitoring, the ESOOS
identified almost 400 overdoses related to carfentanil, a fentanyl analog, in 2016,
allowing the CDC to raise funding for specific areas affected by carfentanil. Furthermore,
the ESOOS allowed the consolidation of overdose data across ten states that
demonstrated over 50 percent of fatal overdoses attributed to fentanyl and fentanyl
analogs (Centers for Disease Control and Prevention, 2020a).
State Opioid Response Program
Florida DCF has also received SAMHSA funding to manage the State Opioid
Response Program (SOR) (Florida Department of Children and Families, 2019). This
program is designed to address preventative measures in combating the opioid epidemic
and decreasing opioid-related mortalities. One aspect of the SOR program is to bolster
DCF’s Overdose Prevention Program, responsible for distributing and training of use
related to the emergency opioid antagonist naloxone. The SOR grant funds are also used
to purchase and distribute extended-release naltrexone, an intramuscular medication that
has been approved by the Food and Drug Administration (FDA) for the treatment of
opioid use disorder and alcohol use disorder as an option for medication-assisted
treatment (MAT) (Florida Department of Children and Families, 2019; Substance Abuse
and Mental Health Services Administration, 2020).
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State of Florida Response
Governor Scott issued an Executive Order 17-146 in 2017 directing the Surgeon
General of Florida to declare the opioid epidemic a Public Health Emergency (Exec.
Order No. 17-146, 2017; Philip, 2018). Also included within the Executive Order was a
stipulation that all emergency responders have access to emergency opioid antagonists by
way of a standing order. Law enforcement would additionally receive funds through a
state-operated, federally funded grant, managed by the Department of Children and
Families (DCF), in order to disperse naloxone across participating departments. In
addition to this funding, law enforcement officers would also be eligible to receive
additional grant funding for naloxone through the Helping Emergency Responders Obtain
Support (HEROS) grant through the Department of Health (Philip, 2018).
Pain Clinic Legislation
In the early 1990s, physicians and pain clinics geared towards prescribing
patients’ opioids to relieve chronic non-malignant pain began establishing themselves
across the state of Florida, gaining a heavier presence in the early 2000s (Delcher et al.,
2015; Kennedy-Hendricks et al., 2016; Philip, 2018; Spencer, 2019). These clinics, along
with specialty providers, became known as “pill mills” for the rapid rate at which clients
were seen and prescriptions for controlled substances were offered, typically outside the
standards for prescribing practices and medical scope of practice.
When these physicians and pain clinics initially established themselves, there was
little oversight from the state in regulating their prescribing practices. Due to increased
demand for opioids and the proliferation of pill mills across the state with little to no
regulation, it was found that 90% of the physicians purchasing the highest volume of
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oxycodone were practicing in the state of Florida, with a total of 85% of oxycodone
prescriptions nationwide coming from Florida (Johnson et al., 2014; Kennedy-Hendricks
et al., 2016). With the rapid increase in prescribing and market saturation in Florida, there
was a significant rise in opioid-related mortality.
With the majority of prescriptions for opioids being written and filled in the state
of Florida, many out-of-state individuals would travel to Florida to obtain cheap, quick
opioids. The creation of the “pill mill tourist” was evident in the parking lots of many
pain clinics and physician offices prescribing opioids where cars with out-of-state license
plates would camp out overnight and line up early in the morning before taking the
opioids back across state lines (Spencer, 2019). This created compound issues for law
enforcement because law enforcement training related to narcotics did not address legal
prescriptions for illegal purposes or how to manage the influx of “pill mill tourists.”
In an effort to contend with physician and pain clinic negligence, Florida enacted
legislation in 2010 and 2011 that addressed physician ability to dispense controlled
substances on-site, specifically prescription opioids (H. 7095, 2011; Kennedy-Hendricks
et al., 2016; Philip, 2018; Spencer, 2019). This legislation also imposed more stringent
penalties for overprescribing opioid medication (H. 7095, 2011). In response to this
newly imposed legislation, law enforcement took action to arrest and charge physicians
and pain clinic staff for violating the new prescribing laws. Florida law enforcement
received funding, totaling 3 million dollars, to arrest and prosecute physicians,
prescribers, and pain clinics that operated in violation of the new laws (Spencer, 2019).
There was a noticeable reduction of registered pain clinics within a one-year time
frame as a result of the harsher guidelines regulating pain clinics and immediate law
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enforcement response. From 2012 - 2013, the total number of registered pain clinics in
the state of Florida decreased from 921 to 441. In 2014, there were a reported 371 pain
clinics registered and operating in Florida (Spencer, 2018). By 2015, the Florida state
Senate had introduced and passed legislation making the regulation of pain clinics
permanent and outlined provisions for repealing the legislation in the future (S. 450,
2015).
As reported by Philip (2018), the fatal opioid-related overdose rates decreased
initially with the implementation of the new legislation and initiatives by law
enforcement, mirroring an overall decrease in prescribing rates; however, there was a
notable increase in opioid-related mortality in 2013. Since this resurgence, the mortality
rate related to opioid overdoses has continued to rise, indicating the need for a more
comprehensive approach to the opioid epidemic outside of solely reducing the
availability of prescription opioids.
An evaluation of the effect of the Florida legislation and law enforcement
initiatives targeting pain clinics, aka “pill mills,” was conducted by Kennedy-Hendricks
et al. (2016). To measure the effectiveness of these initiatives, the authors examined
mortality data between 2003 - 2012 in the state of Florida to determine the changes in
fatal opioid-related overdoses. The authors also examined data from another state, North
Carolina, as a comparison group. The study results showed a decrease in fatal opioidrelated overdoses over a 34-month period, with approximately 1,029 lives saved as a
result of the combined initiatives of the State and law enforcement (Kennedy-Hendricks
et al., 2016). Additionally, the authors noted a gradual increase in the reduction of
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opioid-related deaths per 100,000 people to be 2010 - 2013 by 0.6, 1.8, and 3.0,
respectively.
Rebound Effect
An unintended consequence of the legislation directed towards regulating the “pill
mills” in the State of Florida was what can be referred to as a rebound effect. The
rebound effect describes how the decrease in opioid prescribing and availability lead to
an increase in consumption of other opioids. Between 2010 - 2012, the state of Florida
enacted several articles of legislation geared towards combating prescription opioid
overprescribing and overdoses (Johnson, Paulozzi, Porucznik, Mack, & Herter, 2014).
This legislation had a significant impact, with overall overdoses attributed to prescription
opioids, such as oxycodone and hydrocodone, declining to 11%. Specifically, overdoses
attributed to oxycodone declined by 52.1%. Florida’s PDMP alone has been attributed to
a 25% reduction in oxycodone-related deaths (Delcher, Wagenaar, Goldberger, Cook,
Maldonado-Molina, 2015).
With the more stringent laws focused on decreasing the availability of
prescription opioids and pain clinics being raided on a nearly daily basis, many
individuals turned to the cheapest alternatives, heroin and other synthetic opioids (Philip,
2018; Spencer, 2019). Although this led to an overall reduction in the number of
prescription-related mortalities, there was a startling effect on opioid-related deaths.
Between 2010 - 2012, Johnson, Paulozzi, Porucznik, Mack, and Herter (2014) reported
that while prescription drug overdoses declined, heroin overdoses began to rise.
This was most evident in 2018 when the opioid-related mortality rate in Florida
jumped nearly 67 percent from the pinnacle of the “pill mill” emergency. In essence, the
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longer the “pill mills” remained unregulated, the more opioid-addicted individuals they
created. When they were closed or regulated more stringently, individuals had no other
options to satiate their addiction than to resort to heroin and other synthetic opioids.
Florida Legislation
In 2015, the Emergency Treatment and Recovery Act was introduced into
legislation in the state of Florida. This act provides immunity from liability and
professional sanctions to first responders who administer emergency opioid antagonist
treatment to an individual experiencing an overdose (H. 571, 2015). It also allows for the
storage and possession of opioid antagonist medication by first responders.
In 2016, the Florida state legislature took another step in combating the opioid
crisis by submitting and passing House Bill 1241 (HB 1241) (H. 1241, 2016). HB 1241
allowed pharmacists and other distributors to provide a standing order for either
intramuscular or intranasal naloxone. The expanded patient, caregiver, bystander, family,
and friend’s access to naloxone. This furthered the harm-reduction strategies of
communities in combating the opioid epidemic by expanding access to preventative
measures used in treating opioid overdoses.
The Florida House of Representatives also passed House Bill 249 (HB 249) in
2017, which required the reporting from emergency departments and emergency
responders any controlled substance-related overdoses, whether fatal or non-fatal (Drug
Overdoses, 2017; H. 247, 2017). This reporting was made to the Department of Health,
who would then direct funds and resources to areas identified as needing more assistance
to combat overdoses. Moreover, this bill stipulated that individuals who initiate a report
to the Department of Health are immune to penalization. Those who fail to make a report
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shall not receive any disciplinary action against their professional license. Quarterly
reports with the reported information from emergency rooms, hospitals, and emergency
responders will be disseminated to “the Statewide Drug Policy Advisory Council, DCF,
and the Florida FUSION Center” to target areas that need funding for increased responses
to controlled substance overdoses in their area (Drug Overdoses, p. 5, 2017). HB 249 also
suggested an amendment to previous legislation and required emergency departments to
develop and implement guidelines for the prevention of controlled substance-related
overdoses (H. 249, 2017). This specifically addressed providing alternatives to opioid
prescriptions.
Additional legislative measures taken to address the opioid epidemic came via
House Bill 21 (HB 21), also referred to as the Controlled Substances Act, which was
passed in July of 2018 (H. 21, 2018). The bill had several stipulations, specifically
targeted towards the physicians and medical providers within the state. It outlined the
necessity for ongoing education and training expressly related to the prescribing of
controlled substances. HB 21 also required the establishment of a three-day limit for
prescribing opioids for acute pain and allows for providers to request a four-day
extension to maximize for seven days in some instances. (H. 21, 2018; Hincapie-Castillo,
Goodin, Possinger, Usmani, & Vouri, 2020; Philip, 2018). Additionally, this bill also
enacted more stringent regulations of the pain management clinics within the state and
broadened the access of providers to the Prescription Drug Monitoring Program.
The quality of HB 21 was evaluated by Hincapie-Castillo, Goodin, Possinger,
Usmani, and Vouri (2020). To measure its effectiveness, Hincapie-Castillo and his team
examined the number of prescription claims dispensed between January 2015 to March
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2019 through the use of a single health care plan. Before the implementation of HB 21,
an average of 5.5 patients per 1000 enrollees were prescribed opioid medication. Since
the implementation of HB 21, there was a significant decrease in opioid dispensed
enrollees, showing a 2% decrease in opioid prescription and a decrease in the average
daily supply of opioids, from 6.5 to 4.2 days (Hincapie-Castillo et al., 2020).
A similar policy was also implemented in Washington state ahead of HB 21 with
notable improvements. Osborn, Yu, Williams, Vasilyadis, and Blackmore (2017)
measured the changes in provider prescribing patterns after implementing changes in
prescription policy guidelines for hospital emergency departments. Participants (N = 336)
were prescribed opioids at the hospital emergency department at least one time over
seven years. Results indicate over providers issued 25,000 opioid prescriptions between
2007 and 2014, with 25-40% of emergency department visits resulting in an opioid
prescription. After implementing the policy changes between 2011-2014, opioid
prescription visits declined, averaging 13-18% (Osborn et al., 2017). The rate of opioid
prescribing in hospital emergency departments fell by nearly 50%, demonstrating
moderate support for policy changes in prescription opioid guidelines as seen in HB 21.
In 2018, the state of Florida enacted Title XXXII, 456.44 (6), which stipulates
that any individual who is treated by a physician with opioids for pain management
related to injury shall also receive a concurrent prescription for naloxone or another form
of an emergency opioid antagonist (Davis, 2018; Regulation of Professions and
Occupations, 2018). Moreover, statute Title XXIX, 381.887, addresses the “emergency
treatment for suspected opioid overdose,” specifically authorizing law enforcement
officers the ability to “possess, store, and administer” naloxone (Public Health, 2018).
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OxyContin and Oxycodone
OxyContinⓇ was developed by Purdue Pharma L.P. and approved by the FDA in
1995 for the management of moderate to severe pain when more than a few days of
opioid analgesic is indicated (Anderson, Fritz, & Muto, 2002). It contains the semisynthetic opioid, oxycodone. Oxycodone is structurally similar to that of codeine and of
equal potency to that of morphine in the production of analgesic effects. Oxycodone in
various formulations has been available since 1917. OxyContin is the controlled-release
form of oxycodone. This means that the drug has an initial rapid release from the coated
tablet surface, which is later accompanied by the slow release of the rest of the
oxycodone over a 12-hour period (Anderson, Fritz, & Muto, 2002).
OxyContin is typically prescribed as an oral medication that many substance
abusers either crush to inhale or to make it more soluble for injection (Cicero, Ellis, &
Surratt, 2012). In response, a supposed abuse-deterrent formulation of OxyContin was
released in 2010 (Severtson et al., 2016). An overall decrease in the abuse of OxyContin
was observed after the release of the abuse-deterrent formulation, with a slight increase in
other opioid analgesics (Cicero et al., 2012; Severtson et al., 2016).
In Florida, oxycodone related mortality increased by 118.3% per 100,000 people
between 2007 and 2010 (Delcher, Wagenaar, Goldberger, Cook, & Maldonado-Molina,
2015; Lee, Delcher, Maldonado-Molina, Bazydlo, Thogmartin, & Goldberger, 2014).
This is in stark contrast to the mortality rates of hydrocodone (16.3%), methadone (13.8%), fentanyl (-5%), morphine (0.1%), and hydromorphone (62.4%). The prescribing
of opioid analgesics and related overdoses peaked near 2011; however, there has been an
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overall decrease in prescribing and opioid analgesic related overdoses since that period of
time (Rose, 2018).
Heroin
Pharmacologically, heroin is similar in composition to prescription opioids
(Compton et al., 2016; National Institute on Drug Abuse, 2020b). As individuals shift
away from consumption of prescription opioids, there has been an increase in illicit
opioid consumption, specifically heroin and fentanyl, since 2011 (Cicero et al., 2014;
Compton et al., 2016; Rose, 2018). More recently, individuals have reported initially
using prescription opioids, but later transitioning to heroin due to ease of access and
lower cost. There has also been a noticeable shift in demographics of consumers who
have switched from prescription opioids to heroin, with the majority (90%) being white
and in less urban areas (Cicero et al., 2014). Although there appears to be conflicting data
regarding whether individuals are more likely to use heroin or prescription opioids first,
the data does suggest that individuals who use one are at a significantly higher likelihood
of using the other (Cicero et al., 2014; Compton et al., 2016; National Institute on Drug
Abuse, 2020b). Additionally, Philip (2018) reported as opioid analog use and prescription
opioid use is on the rise again, the arrests and charges associated with heroin are
decreasing.
Synthetic Opioids
Prior to 2013, overdose deaths related to fentanyl and fentanyl analogs were
considered to be sporadic with a low overall impact on mortality (Armenian et al., 2017).
Since 2016, the U.S. Department of Justice has steadily begun increasing its monitoring
of synthetic opioids. In response to recent spikes in seizures from the Drug Enforcement
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Agency throughout 2016 and presence of synthetic opioids in overdose victims, fentanyl
and fentanyl analogs were temporarily added as Schedule I substances (Eklholy, 2016;
U.S. Department of Justice, 2016; U.S. Department of Justice, 2018).
Fentanyl
Fentanyl is a synthetic opioid that has an approved medical use for the treatment
of severe pain, most often prescribed for cancer patients in advanced stages (Centers for
Disease Control and Prevention, 2021). It has recently been linked to an increase in
overdose deaths due to its potency. Reports indicate fentanyl can be anywhere from 50 –
100 times stronger than morphine (Centers for Disease Control and Prevention, 2021). It
is often consumed as a powder combined with other opioids to increase euphoric effects
or can be taken in lozenge form or as a transdermal patch and absorbed through the skin.
The transdermal patches have presented a new challenge for many law enforcement
agencies in successful overdose reversals if the patch is not found and removed.
In response to the introduction of the abuse-deterrent version of OxyContin, some
studies have found an initial increase in fentanyl use by as much as 12% (Cicero et al.,
2012), although other studies present conflicting data (Severtson et al., 2016). While
there is mixed data regarding fentanyl use, the arrests and charges related to fentanyl are
rising per 2018 reports (Philip, 2018). According to Elkholy (2017), the “2016 Emerging
Threat Report & Substances of Concern” added fentanyl to the top of the list for opioids
and analgesics due to the reported increase in seizures by the Drug Enforcement Agency.
Bode et al. (2017) reported that fentanyl laced heroin had potentially contributed to a
significant increase in opioid overdose cases in Miami, Florida. The authors additionally
noted the increased number of naloxone doses per overdose increased likely as a result of
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the addition of fentanyl. To highlight the significance of fentanyl potency, the authors
noted a 476% increase in naloxone utilization between 2015 – 2016 paralleling the
perceived spike in fentanyl laced heroin overdoses (Bode et al., 2017).
Fentanyl Analogs
Fentanyl analogs are physically and chemically similar to that of fentanyl.
Elkholy (2017) noted three analogs of emerging concern as a result of increased seizures
by the Drug Enforcement Agency including furanylfentanyl, acetylfentanyl, and U47700. U-47700 acts similarly to morphine and has not been identified to have any
medical use (U.S. Department of Justice, 2016). As of a 2016 U.S. Department of Justice
Report, U-47700 is being identified more frequently in instances of drug overdose, either
singularly or combined with heroin or other fentanyl analogs, which indicates its
propensity for abuse due to its similarity to morphine, heroin, and other prescription
opioids.
Prior to 2015, the Drug Enforcement Agency has no documented cases of
overdose deaths associated with U-47700. This demonstrates the rapidly shifting market
of opioid analogs and synthetic replacements for opioids making it even more difficult to
regulate and place these substances into a schedule (U.S. Department of Justice, 2016).
Many of the new synthetic opioids and fentanyl analogs are marketed as research
chemicals that are easily available online often containing inaccurate information related
to the substances’ purity and potency. This increases the risk of adverse health effects and
incidence of overdose to the potential buyer (U.S. Department of Justice, 2016; U.S.
Department of Justice, 2018).
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Opioid Antagonists
Every person has endogenous opioids that interact with opioid receptors in their
Central Nervous System. Endogenous means that they are something that we create
internally and naturally (Health Care Resource Center, 2019). Opioids that are not
endogenous, making them exogenous, typically fall into one of three categories: full
agonist, partial agonist, and antagonist. Full agonists include substances such as heroin,
oxycodone, fentanyl, and morphine. This group of drugs is considered full agonists
because of the way the opioid tightly binds to the receptor, allowing this class of agonists
to produce the most powerful reaction. Buprenorphine and tramadol make up some of the
partial agonists which produce lesser effects than full agonists. Partial agonists also create
less of an impact the higher the dosage (Health Care Resource Center, 2019). Antagonists
are exogenous opioid receptor blocking drugs used to reverse the effects of other
exogenous full and partial opioids. The group of antagonists include Naltrexone and
Naloxone.
Although it may seem like a fairly new drug, Naloxone has been in existence for
over 60 years. It was initially developed and patented in 1961, later receiving FDA
approval in 1971 as a means of opioid abuse treatment (Cordant Health Solutions, 2017).
Alone, Naloxone can be used as an emergency intervention to reverse the effects of an
opioid overdose. Naloxone may need to be administered more than once to reverse the
effects of the opioid, depending on the amount consumed and the tolerance of the
individual. Naloxone is also metabolized quite quickly and this may increase the need for
re-administration should the overdose recur (Cordant Health Solutions, 2017).
Additionally, Naloxone may trigger withdrawal symptoms when administered to
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someone who is addicted to opioids. If Naloxone is administered to someone who does
not have opioids in their system, there are little to no side-effects. It can now be found in
Suboxone, an approved medication for the treatment of opioid addiction (Health Care
Resource Center, 2019).
Naloxone Access
Naloxone is not classified as a controlled substance and has been used by
paramedics and other medical professionals to reverse the effects of an opioid overdose
for over 40 years (Davis & Carr, 2017). The increased availability of naloxone without a
prescription to friends and family members, as well as opioid abusers, has the potential to
reduce opioid-related deaths (Compton, Boyle, & Wargo, 2015). Professional
organizations including the American Medical Association, the American Pharmacists
Association, and the National Association of Boards of Pharmacy are in agreement about
the necessity of enhancing availability to friends and family members of opioid users
without a prescription (Davis & Carr, 2017).
Moreover, the CDC identified Naloxone as a “critical tool in preventing fatal
opioid overdoses” and issued a statement in support of expanded access (Centers for
Disease Control and Prevention, 2021). As of 2016, a total of 44 states had enacted
“third-party laws” allowing naloxone to be prescribed to any person who may reasonably
exist in a position to help a person who may experience an overdose. Additionally, 40
states have laws enabling a “non-patient specific standing order” (Davis & Carr, p.S181,
2017). This allows pharmacists to dispense naloxone to any individual deemed at risk of
an overdose.
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Some barriers to naloxone as a harm reduction strategy in response to increased
availability were addressed by Gatewood, Van Wert, Andrada, and Surkan (2016). The
authors surveyed physicians and medical students and identified the biggest concern with
how naloxone addresses addiction. Participants in the study reported that naloxone
prevents the acute opioid overdose but fails to address the cause of addiction and
prescription drug abuse (Gatewood et al., 2016). Moreover, many physicians and medical
students expressed significant concerns related to their ability to communicate how to
recognize the signs of an overdose and knowledge of when to administer naloxone to
third parties. Many participants also raised concerns that naloxone gives clients
permission to continue using opioids and provides them with a false sense of security.
Financial Impact
Naloxone is the most commonly prescribed opioid receptor antagonist. It is also
referred to by its brand name, Narcan®, and can be administered intravenously,
intramuscularly, or intranasally. Due to the increased demand for providing kits to
community agencies, pharmacies, and friends and family of people with an opioid
addiction, the price of Naloxone has increased substantially. There are several
contributing factors to this unfortunate increase in price.
First, Naloxone has several different purposes and is considered to be a “postpatent generic drug” (Beletsky, Burris, & Krall, 2008). It is considered medically
approved for the reversal of opioid overdose, reversing anesthesia in hospital settings,
and in combination with other drugs it can be used as a MAT for deterrent of opioid use.
Second, the few companies that market and distribute Naloxone have been raising
the wholesale price of the product with the increased demand in response to the opioid
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crisis. For example, Denvir (2017) reported that the pharmaceutical company kaléo had
the largest price increase for their product, Evzio. When kaléo first came on the market in
2014 with Evzio the price of a two-dose package cost $690. After two years on the
market, the price rose approximately 500 percent, costing state and local governments,
laypersons, and community agencies $4,500 for two doses (Denvir, 2017).
Even with the staggering cost of Naloxone, sales have continued to increase as a
result of the continued opioid crisis. State and local governments have felt the impact of
the price hikes acutely, making the purchasing of Naloxone for community agencies and
first responders increasingly more difficult (Denvir, 2017). Many areas do not have
enough funds in their budgets initially to allocate additional funds sufficient to cover the
amount of Naloxone kits needed to aid in combating the opioid epidemic. State and local
law enforcement and emergency responder agencies have become the primary consumers
of Naloxone, although the ever-increasing prices of the kits make them inaccessible to
community agencies and first responders. As a result, agencies have a limited number of
doses they are able to purchase and supply to community members and law enforcement
officers as a means of treating opioid overdoses (Denvir, 2017). These agencies are
further impacted as the number of doses per individual is dependent on the potency of the
opioid or synthetic opioid they have consumed. The CDC indicates that due to the high
potency of fentanyl and fentanyl analogs, most individuals may require repeated doses of
naloxone for successful reversal (Centers for Disease Control and Prevention, 2021).
Criminalization of Substance Abusers
President Richard Nixon initially declared the “war on drugs” in 1971 with
measures that ultimately increased the funding for federal agencies monitoring and
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enforcing drug laws (Drug Policy Alliance, 2021). Additionally, legislation pushed
through by President Nixon also included the provision of no-knock warrants and
minimum mandatory sentencing. State level legislation soon followed in the form of the
Rockefeller Drug Laws (Sayegh, n.d.). The New York State governor introduced a series
of legislation in 1973 intended to target large scale drug operations. These laws mandated
prison time for minimal amounts of substance possession regardless of mitigating
circumstances (i.e., first time offense, role, circumstances of the arrest). The introduction
of these laws also prohibited the justice system from diverting substance users to
community-based treatment programs demonstrating a shift towards criminalization of
substance users and away from medical and therapeutic treatment for addiction (Sayegh,
n.d.). Continuing the “war on drugs”, President Ronald Reagan’s wife, Nancy Reagan,
initiated the anti-drug campaign that was the basis for the zero-tolerance policies and the
D.A.R.E. program during the 1980’s (Drug Policy Alliance, 2021). Consequently, harm
reduction interventions including needle-exchange programs and expansion of
community-based substance abuse treatment programs were blocked.
As a result of the “war on drugs” and being tough on crime, there has been an
enduring stigma attached to substance abusers. Many of these stigma’s center on the idea
that substance abusers deserve what happens to them and that they bring overdoses on
themselves or that substance abusers deserve prison time for breaking the law as opposed
to diversion to community-based treatment for addiction (Davis and Beletsky, 2009).
Interventions geared towards prevention and intervention have been looked upon
unfavorably by the general public and law enforcement, alike, as they are considered to
involve a lack of consequences and have the potential to increase substance use
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(Beletsky, Burris, & Krall, 2008). These interventions include drug court, needle
exchange programs, safe use zones, and naloxone programs. Drug courts, specifically, are
in direct contradiction to the “tough on crime” approach of law enforcement utilizing the
ideas of therapeutic jurisprudence (Loue, 2003).
Criminalization of substance users is also apparent in the generally held belief that
substance abuse and addiction are a choice, as opposed to the widely accepted medical
model supporting the classification of addiction as a disease wherein the brain circuitry
and functioning is affected (Loue, 2003). This stigma has prevented both legislators and
public health agencies from shifting away from the pervading attitudes on drugs towards
viewing overdose deaths and addiction as a public health issue (Davis, 2018b). The
criminal model of addiction is still a pervasive belief in law enforcement and criminal
justice communities evidenced by the support for punitive measures related to first and
second non-violent drug offenders with minimum sentencing standards (Drug Policy
Alliance, 2021; Loue, 2003).
It has also been demonstrated in the law enforcement community via the
“economic compulsive” model proposed by Paul Goldstein in 1985 (Davis, 2018b). This
model suggests that an individual engages in specific types of property crime as a means
of sustaining their drug use. This supports the notion that law enforcement typically
believe substance use to be an issue related to legal and moral principles that is best
resolved through punishment (Davis & Beletsky, 2009). Challenges of this notion were
widespread; however, major research between 2000 – 2011 negated this model and
highlighted regarding the lack of research substantiating that drug users commit non-drug
related crime, as well as the idea that drug use precedes crime for the majority of
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individuals (Davis, 2018b; Menard et al., 2001; Nordstrom & Dackis, 2011; Simpson,
2003). Monaghan and Bewley-Taylor (2013) suggest that embedded harm reduction
standards incorporated into law enforcement training have the potential to change law
enforcement attitudes towards individuals who use drugs.
Law Enforcement as Medical First Responders Although paramedics have
been carrying and administering naloxone for many years prior to the declaration of an
opioid crisis, law enforcement officers are typically the first to arrive on the scene of an
opioid overdose. In rural and urban areas, law enforcement officers typically outnumber
emergency medical technicians and paramedics (Lurigio et al., 2018). Moreover, law
enforcement officers are routinely patrolling high risk areas for substance use which also
increases their ability to respond more quickly than other first responders. This places
them in an exceptionally unique position to administer life-saving interventions such as
cardiopulmonary resuscitation (CPR) and emergency opioid antagonists, like naloxone,
in the amount of time needed to prevent hypoxia-related brain and organ damage (Davis,
Carr, Southwell, & Beletsky, 2015). While some studies show law enforcement is
generally willing to carry and administer naloxone, Berardi et al. (2021) report officers
do not believe this to be in the scope of their professional responsibility and concerns
related to liability.
Training Models and Theories
When developing a training, organizational interest lies in how effective trainings
will be at transferring the information to real-world scenarios and enhancing trainee
competence. This is often referred to as the transfer of training, or the importance of
lasting attitude or behavior change in a job-specific context through positive post-training
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results (Saks, Salas, & Lewis, 2014). Baldwin and Ford (1988) developed a framework
for evaluating an organization’s training and transfer process.
Within this framework, the authors suggest trainee characteristics, the training
design, and characteristics of the work environment all impact training input (Baldwin
and Ford, 1988; Saks, Salas, & Lewis, 2014). These three training inputs impact the
overall training outcomes related to learning and retention of the intended material.
Additionally, Salas et al. (2012) report prior research on training has two main
implications including how training works to enhance particular job-specific skills and
how a training is designed, conveyed to the trainees, and executed.
Factors of Effective Training
Research on transfer of training has detailed the necessity of several important
factors in the creation of effective organizational trainings (Grossman & Salas, 2011;
Saks, Salas, & Lewis, 2014; Salas & Cannon-Bowers, 2001; Salas et al., 2012). Initial
steps generally include the completion of a training needs analysis to determine the
specific needs of the organization (Aguinis & Kraiger, 2009; Salas & Cannon-Bowers,
2001; Salas et al., 2012). This includes determining what material is relevant to train on
and how the material should be delivered to the organization.
Additionally, the authors found that negative attitudes about the training impacted
overall trainee attitudes towards the training. Salas et al. (2012) also reported that
enhanced self-efficacy throughout the training impacts trainee motivation and attitude.
When the trainings focused on increasing individual beliefs about ability to perform the
task, there was increased motivation to participate by trainees and more positive attitudes
about the trainings (Aguinis & Kraiger, 2009; Blume et al., 2010; Salas et al., 2012).
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Moreover, trainings that incorporated factual and conceptual information,
presentations of desired behaviors and attitudes via demonstration, the opportunity to
practice with hands-on training, and supervisor or trainer feedback increased the positive
transfer of training (Aguinis & Kraiger, 2009; Salas & Cannon-Bowers, 2001; Salas et
al., 2012). Although these four concepts are supported throughout the literature to
enhance training, many trainings continue to rely on PowerPoint and video presentations.
Training Facilitator
Additional studies have found that the type of trainer used to conduct
organizational trainings matters as well (Aguinis & Kraiger, 2009; Aragón-Sánchez et al.,
2003). In a review of harm reduction trainings for police officers, Khorasheh et al. (2019)
reported that the training facilitators differed greatly across the opioid overdose and
naloxone trainings. In some instances, the facilitator of the training shifted the focus of
the training from the importance of law enforcement role and harm reduction approaches
to emphasizing pathophysiology and medical approaches to opioid overdoes in the
community. This demonstrates the importance of law enforcement in the facilitator role
and in shifting officer attitude and perception. The authors noted that many trainings
utilized outside facilitators as trainers, mainly from the health sector. This may, in part,
be due to who initially develops the training. In many cases, departments that worked in
conjunction with outside-agency training developers still had a member of their
department, generally someone from the training department or a high-ranking officer,
deliver the training (Khorasheh et al., 2019). This is supported by general training
suggestions for law enforcement regarding including a trainer from a trusted source, often
from within the law enforcement community.
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Blume et al. (2010) conducted a meta-analysis examining the most significant
variables related to positive transfer of training. The authors found that voluntary
participation in training and supervisor and co-worker support impacted positive transfer
of training, although the authors note there were no consistent variables across all
trainings that were significant (2010). These findings highlight the necessity of trainings
to be created with the specific organizational demands and needs in mind.
Post-Training Strategies
Wexley and Baldwin (1986) detail three post-training strategies necessary for
effective transfer of training. The authors indicated that assigned and participative goal
setting not only increased participant motivation, but positively impacted transfer of
training two months post-training. This implies that to facilitate enhanced transfer of
training, trainees should be assigned specific behavioral goals post-training created
independently and collaboratively to monitor learned skills as they are utilized (Wexley
& Baldwin, 1986).
Harm Reduction
Considering the above information related to transfer of training, it is important to
note that the more tailored and precise a training is developed for job-specific context, the
higher the likelihood of positive transfer that will be observed post-training (Aguinis &
Kraiger, 2009). Trainings that are created with a theoretical foundation to guide the
learning process have the ability to positively impact the transfer process as well.
Naloxone trainings are currently viewed as a harm reduction approach to treat substance
use. Harm reduction is based on the concept that addiction lies on a continuum wherein
the goal is to move towards abstinence at one end (Loue, 2003). This framework operates
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under the assumption that small steps towards abstinence are valuable. These steps
typically focus on the safety of the substance user, particularly in social and
environmental contexts (Loue, 2003).
Law Enforcement Training
Davis et al. (2015) suggested in their review of law enforcement naloxone
training that incorporating a view of substance abusers as individuals in need of
assistance, as opposed to criminals breaking the law, might impact police behavior. The
authors posited the change in police perceptions of substance users can decrease police
behavior that increases an individual's risk of overdose and potential for not reaching out
in the event of an overdose. These behaviors include the strict adherence to policing
practices regarding all substance users as criminals and policies detailing management of
individuals found to be in or near drug paraphernalia. These changes are based on the
harm reduction model and principles associated with reframing the view of substance
abusers as criminals to patients in need of treatment and care. Khorasheh et al. (2019)
also highlight the incompatibility of harm reduction strategies with departmental policy
and professional roles, suggesting a need for additional training on the harm reduction
paradigm to enhance officer understanding and rationale for practice.
Both of the aforementioned studies highlight the incompatibility of harm
reduction strategies with current law enforcement culture. With this in mind, how
effective can harm reduction trainings be at transferring important aspects of training to
law enforcement if they are inherently incompatible with the cultural ethos? In the same
sense, if some trainings are more effective at communicating goals and increasing
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positive attitudes towards naloxone programs, what aspects of those trainings are more
likely to be accepted within the law enforcement community?
Opioid Antagonist Training
Naloxone Training Curriculum
There is a large discrepancy across training programs regarding what should be
included when training employees and deputies on opioid overdose and naloxone
administration. Many departments develop their own curriculum with the oversight of the
medical control physician, and some collaborate with the medical control physician or
other outside agencies when presenting their training. Some agencies use the Department
of Health brief training video and post-test; others develop all training materials in-house.
Agencies are at liberty to decide if retraining happens annually or biannually, or in
conjunction with other trainings. The format, objectives, and components of the training
vary by department and place emphasis on different areas of the training across
departments.
The majority of training programs have been developed on the platform of harm
reduction which has been geared towards community policing strategies. This has a core
concept of acknowledging the problem of substance use and attempting to reduce the
criminality associated with drug use. Harm reduction proposes interventions that are
aimed towards rehabilitation as opposed to retribution. In reviewing the prior history of
the “war on drugs” including mass incarceration of substance users and being tough on
crime via implementation of harsher sentences for substance users, the inherent policies
associated with harm reduction are at odds with the policing standard surrounding drugs
and are more aligned with community policing policies and trends.
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Community policing is built upon the idea that the more nonenforcement
interactions the community has with law enforcement, the more their attitudes will shift
towards a positive perspective of police and policing in general (Peyton et al., 2019). One
study found current attitudes towards adversarial policing practices prevented individuals
from seeking help during an overdose despite being aware of harm reduction laws
(Goldenberg et al., 2020).
Studies on harm reduction-based policies, such as amendments to the Good
Samaritan laws and naloxone access policies have generally demonstrated mixed findings
(Abouk et al, 2019; Atkins et al., 2019; Doleac & Mukherjee, 2018; Efranian et al., 2019;
McClellan et al., 2018; Pardo, 2017; Rees et al., 2017). Some studies reported increased
access and administration of naloxone increased abuse (Doleac & Mukherjee, 2018;
Efranian et al. 2019) with no reported reduction in overall opioid mortality (Atkins et al.,
2019; Doleac & Mukherjee, 2018; Efranian et al. 2019).
Doleac & Mukherjee (2018) even indicated that in the Midwestern States, an
increase in access to naloxone within communities was associated with an increase in
both general opioid-related mortality and fentanyl specific related mortality and an
increase in opioid-related crime across the United States. Consistent with the findings of
Doleac and Mukherjee (2018), Efranian et al. (2019) reported that the laws allowing for
increased access to naloxone do not decrease opioid-related mortality but increase the
overall opioid-related deaths in specific regions across the United States.
Abouk et al. (2019) found that the specific type of naloxone access law was
important, indicating only naloxone access laws geared towards pharmacists were
associated with a reduction in overall opioid-related deaths. Other studies found the
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implementation of harm reduction-based policies to be associated with a reduction in
opioid-related mortality rates (McClellan et al., 2018; Rees et al., 2017). Based on the
available research, there is little evidence to suggest a positive association between the
implementation of harm reduction-based policies and a reduction in opioid-related
mortality.
Naloxone Training Core Objectives
In a review of the types of harm reduction trainings developed for law
enforcement, Khorasheh et al. (2019) found that there were varied formats of delivery,
duration, content, location of delivery, and the developer/facilitator of trainings. The
content for naloxone trainings generally focused on drugs and drug use, drug-related
health harms, harm reduction philosophy, laws and policies related to drugs and harm
reduction, occupational safety and health, police attitudes and behaviors, and police
policies utilizing harm reduction. Trainings included PowerPoint slide and oral
presentation, hands-on activities, an online video and videos with animated scenarios,
lecture-based presentation, field visits, and role-play activities (Khorasheh et al., 2019).
As for naloxone administration, it is recommended by members of the medical
community that prior to naloxone administration, a patient assessment be completed to
assess respiration followed by cardiopulmonary resuscitation (CPR) with a bag-valve
mask for supportive respiration if needed (Boyer, 2012). Following assisted respiration,
the initial dose of naloxone should be administered. Subsequent doses at increasing
increments (0.5mg, 2mg, 4mg, etc.) are recommended if respiration does not increase
after a 2- minute period. Sheriff’s departments in Florida (N=56) who participated in the
qualitative analysis conducted by this author were found to have varied directions related
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to pre- and post- naloxone administration steps, steps for performing a patient
assessment, and inclusion of personal protective equipment in CPR instructions. Times
for the second dose of naloxone also varied from 2 – 3 minutes to 3 – 5 minutes based on
department, with a number of departments not mentioning a second dose of naloxone in
their training.
Also included in the qualitative analysis of Sheriff’s departments across the state
of Florida was an evaluation of naloxone training core components which found
variations regarding when to contact EMS, whether or not to update EMS, and how to
proceed if a patient refuses follow up medical care when EMS arrives. Additional
variations in training were found in covering Marchman Acts and Baker Acts, reviewing
relevant laws and policies, post-naloxone administration patient withdrawal symptoms
and combativeness, what to do when responding to an opioid overdose call, and the
duration of naloxone effects in relation to risk for additional overdose.
Few departments mentioned managing officer exposure to opioids and self or
partner administration of naloxone, K-9 risk and administration of naloxone, law
enforcement role in the opioid epidemic, harm reduction, and officer liability for
administering or not administering naloxone. Moreover, few departments reviewed the
cost of naloxone, what not to do when responding to an opioid-overdose/myths, naloxone
allergies, and administering naloxone to special populations. Monaghan and BewleyTaylor (2013) and Davis and Beletsky (2009) both mention the importance of including
harm reduction principles in training to shift negative policing attitudes towards
substance users.
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Evaluation of Naloxone Training
Significant variation lies across naloxone trainings, most evident in the content,
delivery method, and trainer (Khorasheh et al., 2019). As there is no established bestpractice for the development and implementation of naloxone trainings, departments are
free to develop programs internally or contract with other agencies who already have
established naloxone training programs. Winograd et al. (2020) also reports the lack of
established guidelines for designing or implementing overdose education and naloxone
distribution training.
Meta-analyses and studies focusing on the specific training components relevant
to naloxone training have consistently reported heterogeneity related to the outcomes and
objectives for law enforcement (Davis & Beletsky, 2009; Khorasheh et al., 2019).
Khorasheh et al. (2019) noted seven of the studies reviewed did not include information
about who created the training or facilitated the training. Of those studies who did include
this information, it varied from Department of Health, police academy instructors, nonprofit organizations, medical examiners, nurses, emergency medical service staff, and
other sworn law enforcement officers. Khorasheh et al. (2019) also found variation in
single versus multiple session trainings, variation in duration within each single or
multiple method, and variation in location of the trainings. The format of the trainings
was also highly variable and included all of the following: slide assisted oral
presentations, hands-on activities, training and/or demonstration videos, lecture-based
presentation, computer-based training modules, and field visits. Khorasheh et al. (2019)
also mentioned the training content varied and was often vague and lacked detail
covering general overview of topics related to harm-reduction or overdose recognition.
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In the qualitative analysis of participating Sheriff’s departments across the state of
Florida (20 out of 56 departments submitted training materials), the format of training
varied greatly given the information submitted to this author. The majority of
departments reported to using PowerPoint presentations as their main source of training
(55%). 40% of departments reported to utilizing a computer-based presentation,
application, or primarily video training and 35% of departments reported to providing
handouts to their trainees. Of the participating departments, 25% reported to
administering a post-test and 20% reported to including hands-on training and
demonstrations. An evaluation of the information provided to this author indicated 40%
of the departments utilized multiple methods and a variation of formats with 60% of
departments utilizing a singular format.
Based on Khorasheh et al. (2019) and the qualitative analysis presented, there is
generally no consistency across trainings in the format or implementation. This creates
difficulty when evaluating best practices for transfer of training related to naloxone
programs for law enforcement. An evaluation of these trainings is additionally
compounded by the fact that there is little research conducted to date supporting the
method of training most likely to produce best outcomes when responding to opioidrelated overdose calls.
As Davis (2018a) mentioned, there is a large-scale shift in providing more access
to naloxone to the general public and incorporating law enforcement in harm reduction to
combat increasing opioid-related morbidity and mortality. This shift necessitates a
thorough understanding of the effects policy changes have on the opioid crisis and the
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evaluation of law enforcement emergency interventions that have the intended effect in
the communities that provide them.
As reported earlier, harm reduction strategies utilized in naloxone trainings are
generally at odds with the “tough on crime” nature of policing. While trainings vary
across states, as well as within the states, there has yet to be a formal evaluation of
naloxone training program components in general. This prevents the formal development
of well-designed trainings, limits knowledge of how training impacts officer policing
practices, and provides little information about the effectiveness of trainings in achieving
targeted outcomes (Davis & Beletsky, 2009; Khorasheh et al., 2019).
General inconsistencies across trainings include the duration of training and how
much training was provided, training components, the police officer rank/years of
service, and the occupation of the program trainer. Khorasheh et al. (2019) also note lack
of details provided in how a training program was developed and little to no trainings
grounded in pedagogical theory. The authors also note many of the trainings failed to
incorporate content related to interacting with opioid users and no hands-on training (e.g.,
how to assemble and administer intranasal naloxone). This was also generally supported
in the qualitative analysis conducted by this author.
Several studies indicate the implementation of naloxone administration by law
enforcement impacts the overall mortality rate associated with opioid overdoses (Enteen
et al., 2010; Lurigio et al., 2018; Rando et al., 2015). Ray et al. (2015), White et al.
(2021), and Purviance et al. (2017) each reported positive effects of naloxone training on
officer attitudes, perceptions, or competence. In addition to these studies, Khorasheh et
al. (2019) and Wagner et al. (2016) reported officers believed their training was effective.
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Winograd et al. (2020), however, reported officers who participated in their study
reported more negative attitudes post-training.
There is some inconsistency across studies regarding the specific aspects of
training (i.e. group size, who conducted the training, and the duration of training) that
may impact effectiveness outcomes. While studies have examined the overall general
impact of their training programs, there has been little attention to the specific aspects of
training that contribute to these outcomes. For example, a study by Ray et al. (2015) was
conducted in 20 – 25-minute periods over a two-week time span by three separate
trainers. Winograd et al. (2020) reported the training attendance ranged from seven
participants to 75 and took place over three hours with four trainers. Murphy and Russell
(2020) included 515 male officers and 29 female officers in their survey; however, 67
officers did not provide demographic information. Ray et al. (2015) administered the
training to 119 officers with 117 completing the additional post-training survey. White et
al. (2021) included 240 officers in their pre-training survey and 117 officers in the posttraining survey. Purviance et al. (2017) conducted their training and administered their
survey to 97 officers. Winograd et al. (2020) administered the pre-test to 729 officers and
post-test to 603 officers. Murphy and Russell (2020) included a sample of 618 officers
from 21 different counties across the state of Pennsylvania. Given the considerable
variability in the number of officers trained across studies, little can be concluded about
the impact of officer class size and duration on the response to training.
Ray et al. (2015) reported the content of their training focused on
“pathophysiology of opioid overdose, need for law enforcement naloxone delivery, signs
and symptoms of opioid overdose using images and videos, how naloxone works and a
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demonstration of how to administer it…, and the intended effects and rare instances of
combativeness following naloxone”. The Ray et al. (2015) training was delivered by
emergency medical services employees. Content of the curriculum and who delivered the
training were not reported by White et al. (2021). Winograd et al. (2020) reported a
licensed professional counselor, emergency medical physician, project manager and
evaluation coordinator all collaborated in the presentation of naloxone training. While
training facilitator and training content may significantly impact training outcomes,
studies have not routinely evaluated the influence of these specific variables on training
outcomes.
Ray et al. (2015), White et al. (2021), Purviance et al. (2017) all used survey data
collection in their studies. Ray et al. (2015) utilized 15 Likert scale items shortened from
the original 28 items of the Opioid Overdose Attitudes Scale. White et al. (2021)
collected 50-question survey data in two separate waves, three months prior to naloxone
training and six months post-training. Purviance et al. (2017) also reported utilizing a preand post-training survey which consisted of 24 of the 28 original items of the Opioid
Overdose Attitudes Scale. Wingrad et al. (2020) used pre- and post-training survey data
collected either online or via paper.
A small proportion of agencies (N=5) in Florida currently do not employ
naloxone policies and trainings. One possible reason suggested by Berardi et al. (2021),
Davis et al. (2015) and Green et al., (2013) is the perceived liability and risk associated
with administration of naloxone. Some agencies have stalled their efforts to initiate
policies and trainings for emergency opioid antagonists as the administration of these
medications puts the officer and agency at risk for litigation. Green et al. (2013) reported
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officers were more likely to carry naloxone for self or partner administration to avoid
litigation by community members.
The lack of consistency and outcome measures related to naloxone training raises
some important issues. One such question is whether or not the focus on opioid overdose
and readiness to respond can cause officers to potentially miss cues to other medical
emergencies with related symptoms. Are officers assessing for the potential of other
medical causes for respiratory disruption, loss of consciousness, miosis, and stupor
(Boyer, 2012)? There are many medical conditions characterized by slowed respiration,
smaller pupils, slurred speech, and delayed reaction as symptoms. Is this placing a higher
burden on the officers and asking them to perform outside of the scope of their
professional responsibilities? Moreover, how can trainings increase self-efficacy related
to the medical differential diagnoses to enhance transfer of training?
This issue is compounded by the fact that many individuals need multiple administrations
of naloxone before consciousness and respiration return to normal. Intranasal naloxone
requires officers to breach an area of personal safety to administer the lifesaving
medication. This puts them at an increased risk for injury when the individual is revived.
Furthermore, a study conducted by Carroll et al. (2020) indicated more than half
of naloxone trained officers reported a need for increased training related to opioid use
disorder or opioid overdose intervention. This indicates the necessity of evaluating what
training factors impact effectiveness of training and officer preparedness to respond to
opioid overdose calls and administer naloxone. Due to a general lack of consistency
across trainings, the need for evaluation of particular limitations of current trainings is
imperative to increase best-practices and positive outcomes.

PERCEPTIONS OF NALOXONE TRAINING

47

Rando et al. (2015) reported a decline in overdoses associated with
implementation of naloxone training in Lorain County, Ohio. The program has reportedly
administered more than 700 doses of naloxone from 2010 – 2015 (Rando et al., 2015).
The North Carolina Harm Reduction Coalition (2018) released documents detailing more
than 1,000 law enforcement administered naloxone overdose reversals and more than 200
overdose reversals due to law enforcement naloxone administration in the state of
Georgia. Dart et al. (2020) also reported a decline in opioid usage and mortality trends
across the United States as a result of public health policies.
Officer Perceptions and Attitudes towards Naloxone Training
To date, several studies (Berardi et al., 2021; Green et al., 2013; Purviance et al.,
2017; Ray et al., 2015; Wagner et al., 2016; White et al., 2021; Winograd et al. 2020)
have focused on how naloxone training impacts officer perceptions and attitudes towards
naloxone training and opioid overdose. The majority of these studies present conflicting
outcomes related to increases in either positive or negative attitudes post-training. For
instance, a study conducted by Ray et al. (2015) reported the majority of officers
throughout the entire Indianapolis Metropolitan Police Department had an
overwhelmingly positive response towards the training and indicated that it’s important
for other officers to attend the training in order to carry naloxone. White et al. (2021)
reported officers stated strong support for carrying and administering naloxone both prior
to receiving naloxone training and after training. Purviance et al. (2017) also found
officers reported increase competency and reduced concerns related to carrying and
administering naloxone post-training.
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In contrast, Winograd et al. (2020) found officers who participated in overdose
education and naloxone distribution training had more negative attitudes after receiving
training. Wagner et al. (2016) reported in their study that the majority of officers held
baseline negative perceptions and stigmas of substance abusers which did not decrease
after receiving naloxone training. Beletsky et al. (2005) also found officers held negative
stigmas towards substance abusers and Formica et al. (2018) reported these negative
stigmas were the most common barrier for officers following through in referring opioid
overdose victims to follow-up treatment programs. Green et al. (2013) and Saunders et al.
(2019) additionally reported that the ongoing opioid epidemic has burnt out many officers
who responded to opioid overdose calls and indicated these officers reported losing
empathy for overdose victims. Similarly, Gnann (2019) also reported negative stigmas
among officers, indicating many officers described naloxone as enabling and expressed
increased frustration towards individuals receiving naloxone on multiple occasions.
Officer Tenure Matters.
Ray et al. (2015) found that officers who had been on the force longer and had
greater experience with responding to opioid overdose incidents maintained more
positive attitudes regarding naloxone training. The authors also found that less
experienced officers had more negative attitudes and rated the training as less important.
The authors suggested that recruits fresh out of the academy were more rigid in adhering
to specific laws, while more tenured officers had higher buy-in to harm reduction
approaches. This suggests that officers with less training, experience, or exposure to the
effects of the opioid crisis might have overall less positive attitudes and view naloxone
training as less important. White et al. (2021) also reported officers who were more
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tenured reported less concern related to liability and did not agree that officer role did not
include responding to overdose calls.
Does Opioid Call Frequency Matter?
This finding was not supported by Murphy and Russell (2020) and Carroll et al.,
(2020) who found officers who responded to more opioid overdose calls had more overall
negative attitudes towards substance users, naloxone administration, and opioid overdose
response strategies. Furthermore, Wagner et al. (2016) found that naloxone training had
no significant impact on officer attitudes and perceptions of substance users post-training.
Conflicting data were presented in a study by Green et al. (2013) wherein officers
reported having negative attitudes towards opioid overdoses if the victim did not have a
prescription for opioids. Additionally, Beletsky et al. (2009) and Green et al. (2013)
reported officers indicated naloxone was viewed as a “get out of jail free card” indicating
the potential for enabling substance use and lack of consequences for opioid overdose.
White et al. (2021) found no significant interaction between the number of responses to
overdose calls and officer attitudes towards persons who use drugs or overdoses.
Officer Perceptions of Enhanced Access to Naloxone.
Another study evaluated officer opinions of take-home naloxone programs and
amendments to the Good Samaritan Law in Seattle, Washington (Banta-Green et al.,
2013). The authors found that officers’ responses to the immunity portion of the Good
Samaritan Law were more negative than positive, with 45% indicating they were
somewhat or strongly opposed to the law. Officers were more evenly split on whether
they supported citizens having the right to possess and administer naloxone (28%
supported, 34% opposed), which was also mirrored in the study conducted by Green et al.
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(2103). The comments provided by officers who were in support of increased access to
naloxone perceived substance use as an illness as opposed to a crime which suggested
acceptance of the harm reduction approach to training.
Perception of Role and Responsibility to Administer Narcan.
Officers who did not support increased access to naloxone indicated it should be
administered by medical personnel, is enabling, and has the potential for misuse. This
highlights officer perceptions that carrying and administering naloxone may exist outside
the scope of their professional responsibilities and has the potential to increase substance
use with a lack of consequences for overdose (Berardi et al., 2021; Banta-Green et al.,
2013). Green et al. (2013), however, found officers believed carrying naloxone was part
of community policing. Similar to the study conducted by Ray et al. (2015), the officers
in this study also reported it was most important to be present at the scene of an overdose
to keep medical professionals safe due to the likelihood for violent reactions postnaloxone administration (Banta-Green et al., 2013).
Officer Knowledge and Preparedness after Naloxone Training
Several studies have focused on naloxone training and its impact on officer
knowledge and preparedness in responding to opioid overdose calls (Banta-Green et al.,
2013; Carroll et al., 2020; Purviance et al., 2017; Wagner et al., 2016; White et al., 2021).
In a review of the literature, naloxone trainings resulted in an increase in officer
preparedness in responding to opioid overdose calls and knowledge related to opioid
overdose (White et al., 2021). Other studies indicated increased competency of officers in
administering naloxone (Purviance et al., 2017; Wagner et al., 2016; White et al., 2021).
Ray et al. (2015), White et al. (2021), Purviance et al. (2017), Khorasheh et al. (2019),
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Murphey and Russell (2020), and Wagner et al. (2016) reported officers believed their
training was effective and would be able to use naloxone when needed.
Chapter 3: Rationale and Proposed Contribution
The overall purpose of the present study is to contribute to the limited research
regarding best practices related to naloxone policies and trainings in law enforcement.
This study seeks to identify a set of guidelines for naloxone training through the
examination of the components, format of delivery, and training facilitators and their
impact on training outcomes. Specific outcomes include officer perceptions of
effectiveness of naloxone training, preparedness to respond to opioid overdose calls,
perceptions of substance abusers, and overall perceptions of naloxone training. Existing
research has provided support for naloxone training and its impact on reducing opioidrelated mortality and morbidity; however, these studies do not identify what components
of training are the most effective (North Carolina Harm Reduction Coalition, 2018;
Rando et al., 2015). This is important because the components of training can impact
officer attitudes and preparedness. As Beletsky et al. (2021) reported, training
components have the ability to negatively impact officer attitudes and perceptions.
Additionally, inclusion of the more effective components can impact the duration of
training and department efficiency.
Training should be tailored to shift negative attitudes of officers away from the
“tough on crime” nature of policing towards a harm reduction approach. Several
suggestions have been made to facilitate this shift such as inclusion of harm reduction
principles (Davis & Beletsky, 2009; Monaghan & Bewley-Taylor, 2013), the inclusion of
strategies to increase occupational safety of officers (Davis & Beletsky, 2009), and
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departmental (i.e., supervisor and co-worker) support of training (Blume et al., 2010).
Including harm reduction as a training component has the ability to reduce stigma
towards substance users and increase positive attitudes towards naloxone in general. The
inclusion of occupational safety has also demonstrated the ability to enhance self-efficacy
during training, while departmental support also increases positive outcomes of training.
To date, no current studies have examined the transfer of training related to harm
reduction principles and compatibility with law enforcement culture in direct relation to
naloxone carrying and administration. Research has also neglected to focus on the impact
of the trainer on the training despite the acknowledgment that officers are more likely to
shift attitudes and perspectives when conflicting information is presented by a trusted
source (Davis & Beletsky, 2009). Khorasheh et al. (2019) and this author both found a
general lack of consistency in delivery and content across trainings related to opioid
response within law enforcement. One significant discrepancy, for example, was the
duration of each training. This is important in relation to law enforcement as training
results in fewer officers who are actively patrolling. As such, the duration of training and
effectiveness of shorter or longer trainings is important not only for consistency, but to
enhance efficiency within a department.
Previously conducted research has also focused on police attitudes towards
substance users. Purviance et al. (2017), Ray et al. (2015) and White et al. (2021) all
report naloxone training positively impacted police attitudes towards substance abusers;
conversely, Beletsky et al. (2021) reported naloxone training increased negative attitudes
towards substance abusers. None of the studies, however, evaluated the aspects of
training that contributed to these positive or negative outcomes. Murphy and Russell
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(2020) also reported negative officer attitudes towards naloxone administration as they
viewed naloxone as enabling. Gnann (2019), Saunders et al. (2019), and Green et al.
(2013) all report officers held more negative attitudes the longer the opioid epidemic
lasted, the more calls they responded to, and the length of time on the job. This points to
the potential for naloxone training to have less impact on officers who have responded to
more opioid overdose calls, administered more doses of naloxone, and have longer tenure
as a sworn officer. As Formica et al. (2018) mentioned, negative attitudes and stigma
towards substance users are the biggest barrier for most officers in following through
with all aspects of naloxone training and policies. Unlike previous studies, the proposed
study will attempt to identify aspects of training that affect officer attitudes and reduce
stigma associated with substance use.
This study seeks to further fill the gap in existing literature by also examining the
role of the trainer in naloxone trainings. The literature clearly suggests in-house or
within-culture trainers have the ability to positively impact transfer of training (Aguinis
& Kraiger, 2009; Aragón-Sánchez et al., 2003). Prior literature reports utilizing
emergency medical services (Ray et al., 2015) for training, while other studies do not
report who conducted the training or the relevant importance of who the trainer is. When
examining qualitative differences between participating Sheriff’s departments in the state
of Florida, this author noted the training departments were in charge of coordinating the
training with some also delivering the training or outsourcing the training to medical
services.
The need for naloxone training continues to be in demand by agencies as the
opioid epidemic persists. These expanded training efforts may lack efficacy based, in
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part, on officer response to the trainer and components of training. The evaluation of
training components and impact of the trainer will inform the development of effective
training programs and improve transfer of knowledge among law enforcement.
Chapter 4: Study Objectives and Hypotheses
Objectives & Hypotheses
The goals and objectives of the present study aimed to assess multiple variables
related to officer perceptions, naloxone training, and attitudes towards substance users.
For the purposes of this study and based on the World Health Organization (WHO)
definition, substance abuse is defined as “any harmful or hazardous use of psychoactive
substances” (WHO, 2020). WHO describes how policies created to address substance
abuse in communities, such as Naloxone policies and training programs, can decrease
public health concerns related to opioid abuse. Naloxone training programs in law
enforcement include a general overview of the identification of opioid intoxication and
overdose signs to enhance the officer’s ability to correctly assess the necessity of
administering an emergency opioid antagonist.
The following study objectives and hypotheses were proposed:
Objective 1: To assess perceived training effectiveness in a transfer of training
framework to determine if the training model is appropriate for law enforcement culture.
Hypothesis 1.1: Officers who report their agency prioritizes naloxone training (i.e.,
perceived organizational support for naloxone administration and safety for
officers, self-rated priority of naloxone training by trained officers) will perceive
their naloxone training as effective.
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Hypothesis 1.2: Officers who perceive naloxone training and administration as
effective will be more likely to agree that the naloxone program is appropriate and
relevant to their position.
Hypothesis 1.3: Naloxone trained officers who perceive naloxone training as effective
will report greater impact of their training in dealing with opioid crisis in their
jurisdiction.
Hypothesis 1.4: Naloxone trained officers who perceive naloxone training as effective
will report less negative stigma towards substance users.
Objective 2: To compare differences between naloxone trained officers who are trained
by a law enforcement officer from those officers who are not on levels of preparedness in
dealing with opioid overdose calls, attitudes toward community-based substance abuse
intervention efforts, and effectiveness of training.
Hypothesis 2.1: Naloxone trained officers who receive training from a law
enforcement trainer will report a higher level of preparedness in responding to
opioid overdose calls.
Hypothesis 2.2: Naloxone trained officers who receive training from a law
enforcement trainer will report more positive attitudes towards naloxone training
and administration.
Hypothesis 2.3: Naloxone trained officers who receive training from a law
enforcement officer will perceive their naloxone training as more effective.
Hypothesis 2.4: Naloxone trained officers who receive training from a law
enforcement officer will provide higher quality ratings of their training.
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Objective 3: To identify the components of naloxone training (i.e., content and mode of
delivery of training) that officers perceive as most important to their training.
Hypothesis 3.1: The majority of naloxone trained officers will identify personal risk
and safety as the most important component of training.
Hypothesis 3.2: The majority of naloxone trained officers will identify hands-on
training activities and demonstrations as the most preferred mode of training.
Chapter 5: Method
Participants
Participants in this study consisted of 82 law enforcement officers who were
trained to administer naloxone as part of their patrol duties who were recruited to
participate in this study. Inclusion criteria in this study included current employment as a
law enforcement officer in the United States, >18 years of age, at an agency that has a
naloxone policy and offers training related to the department policies for emergency
opioid antagonist storage and administration, also referred to as naloxone training.
Officers who had not participated in the department training on naloxone were not able to
participate in the study. Exclusion criteria included employment at an agency that does
not currently have a naloxone policy or training. The participating law enforcement
officers surveyed originated from law enforcement agencies across the United States.
Demographic information for each of the participants were obtained during survey
completion and included officer gender, age range, race/ethnicity, educational
achievement, years of experience as a law enforcement officer, current rank, and current
agency at which they are employed. Additionally, participants were asked if they have
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ever had personal experience with opioid abuse and/or received opioid abuse treatment or
opioid overdose.
Measures
The primary instrument developed for the current study was a survey, which was
provided to agencies in a single, on-line version via Qualtrics. The survey consisted of 56
questions. Survey content included the following items: (a) previous naloxone training
completed by the officer, the components of training, as well as number of training hours
received in the past year (12 questions); (b) frequency of contact with opioid overdoses
and administrations of naloxone, also referencing disparity in response time of other first
responder agencies (4 questions); (c) officer perceptions of the relevance and benefit of
naloxone training for their career (4 questions); (d) officer perception of agency support
for naloxone training (2 questions); (e) officer level of preparedness in responding to
opioid overdose calls (5 questions); (f) officer opinions and attitudes toward substance
users and substance abuse treatment (1 questions); (g) officer perceptions of naloxone
training (5 questions); (h) officer perceptions of naloxone (5 questions); (i) officer
perception of the opioid problem in their jurisdiction (1 question); (j) officer role and
impact in responding to the opioid crisis (5 questions); (k) impact of COVID-19 on
responding to opioid overdose calls (1 question); (l) officer perceptions of limitations in
responding to opioid overdose calls (1 question); and (m) officer demographic
information (8 questions). An additional qualitative question was added to evaluate trends
in memorable aspects and issues related to responding to opioid overdose calls as
reported by officers. Items were evaluated in categories, and individual items were
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evaluated qualitatively for greater descriptive value. Completion of the survey took
approximately ten to fifteen minutes. This survey can be found in Appendix B.
Study Outcomes.
The primary outcomes in the current study included:
a. Officer perceptions of Naloxone training: This component was evaluated via
five questions on the survey, scored on a five-point Likert scale (1=strongly disagree to
5=strongly agree). Questions assessed officer perception of naloxone training as
beneficial to career, relevance of naloxone training for their careers in law enforcement,
if naloxone training should be required of all officers, if officers play an important role in
responding to the opioid crisis, and if the naloxone training is a beneficial use of
departmental funds. A cumulative score for officer perception of naloxone training was
computed by summing the scores from these five items and used for data analysis.
Cumulative scores range from 0 to 25, with higher scores representing more positive
officer perceptions toward the benefits of naloxone mental health training.
b. Officer preparedness in responding to opioid overdose calls: Officer
preparedness was assessed by four questions on the survey, scored on a five-point Likert
scale (1=strongly disagree to 5=strongly agree). Questions evaluated whether officers
perceive they have received sufficient training on responding to opioid overdose calls,
officer knowledge regarding identification of opioid overdose symptoms, officer comfort
in interacting with opioid users, and overall preparedness in responding to calls involving
opioid overdoses. A cumulative score for officer preparedness was computed by
summing the scores from these four items and was used for data analysis. Cumulative
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scores range from 0 to 20, with higher scores representing greater officer preparedness in
responding to opioid overdoses.
c. Officer perceptions of substance users and substance use interventions: Officer
perceptions of substance users and substance use intervention was measured by nine
questions scored on a five-point Likert scale (1=strongly disagree to 5=strongly agree).
Questions assessed whether officers perceived that naloxone is successful at motivating a
reduction in substance use, if naloxone and current substance abuse interventions are
successful, whether naloxone increases substance use, if substance users should be
arrested, whether naloxone decreases likelihood of seeking out treatment, if officers
encounter “frequent fliers” and whether officers believe there should be a limit on the
number of administrations of naloxone to an individual. Seven items were reverse scored.
Scores from the nine items were summed for a cumulative score for officer perception of
substance users and substance use treatment, which were used for data analysis.
Cumulative scores range from 0 to 45, with higher scores representing more positive
officer perceptions of substance users and substance use treatment.
d. Officer perceptions of training effectiveness: Officer perceptions of
effectiveness of naloxone training were measured by four questions scored on a fivepoint Likert scale (1=strongly disagree to 5=strongly agree). Questions assessed whether
officers believe their department has clear policies and procedures for responding to
opioid overdose calls, perceive naloxone training has a positive impact on how officers
respond to the opioid crisis, whether naloxone training positively impacts how officers
handle opioid overdose call, and perceive their department training as sufficient to
respond effectively to opioid overdose calls. A cumulative score for training effectiveness
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was computed by summing the scores from these four items and used for data analysis.
Cumulative scores range from 0 to 20, with higher scores representing greater officer
perception of training effectiveness.
Demographic Variables.
Officer naloxone training is the primary independent variable of interest in this
study. For the purposes of this study, a naloxone-trained officer was defined as any
officer who has completed the department approved training related to the proper
administration, carry, and storage of naloxone. This component was assessed by one
question on the survey asking if the officer is naloxone-trained and was scored as yes/no.
Questions regarding the characteristics of these naloxone officers (i.e., timeframe of
naloxone training, components of naloxone training, trainer of naloxone training, benefit
of naloxone training) were also evaluated for descriptive purposes.
Other independent variables in the study included whether the officers completed
any additional post-academy training in opioid overdose (excluding department naloxone
training), hours of opioid overdose training in the past year, response time of local
Emergency Medical Services (EMS) and Fire Rescue, agency support for opioid
overdose and naloxone training of officers (i.e., whether the agency supports and
prioritizes naloxone training), frequency of contact with opioid overdoses, and limitations
in responding to opioid overdose calls. Officer demographic characteristics including
gender, age, race, education, years of experience, rank, agency where employed, and
familiarity with opioid overdoses were also included.
Data provided by the law enforcement agencies who completed the survey was
also obtained to categorize each agency as “high” or “low” priority based on officer
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perceptions. Specifically, officers answered survey questions related to the priority an
agency places on naloxone training within their department and the peer and supervisor
support for naloxone trainings. Initially, agencies were to be classified as “high” on
priority of training if at least 20% of respondents from an agency report agreement with
agency emphasis on training and peer and supervisor support. Agencies who did not meet
these criteria were to be classified as “low” regarding priority and/or promotion of opioid
overdose and substance abuse training.
Procedure
This study was initiated after receiving the approval of the Institutional
Review Board at Florida Institute of Technology and the Doctoral Research Project
committee (IRB Number 21-085). Data collection took place via an online survey
disseminated through a Qualtrics link via email to law enforcement agencies across the
state of Florida. This survey was emailed in the form of a Qualtrics online survey to each
law enforcement agency that employed at least one officer who completed naloxone
training. Specific names of individuals completing this survey were not collected. The
only identifying information that was obtained using the agency survey was the state for
which the participant was located.
The email sent to each agency was general in nature and stated that the researcher
is collecting data for a dissertation regarding the impact of officer perceptions on
naloxone training and administration. Completion of this survey was entirely voluntary in
nature. Before beginning the survey, participants were directed to an informed consent
page, which informed participants about the purpose of the study, procedure, potential
risks and benefits of participating, confidentiality, voluntary participation and right to
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withdraw from the study, and who to contact with questions about the study. Participants
then selected whether they agreed or did not agree to participate in the study, and those
who agreed were directed to complete the survey. Following the initial consent page,
participants were then prompted to select whether they completed naloxone training.
Those who selected “yes” were then prompted to continue the survey.
Research Design and Data Analysis
The present study utilized a cross-sectional design for data analysis. Descriptive
statistics, including means, standard deviations, and frequencies, were calculated for
participant demographics and primary outcomes (i.e., officer perceptions toward
naloxone training, preparedness to administer naloxone, and effectiveness of training).
The researchers explored a total cumulative score on each of the four primary outcomes.
Group differences between officers trained by law enforcement officers versus those who
are not were evaluated on a number of outcomes. Chi Square tests were used to assess
for differences between groups for categorical variables; non-parametric Mann-Whitney
U tests were used to assess for differences between groups for continuous variables.
Exploratory Regression analyses were conducted to examine the association between
potential predictor variables and training outcomes. Data were analyzed using the
Statistical Package for the Social Sciences (SPSS) –version 28. All analyses were
considered significant at the p<.05 level.
Chapter 6: Results
Participant Demographic and Officer-related Variables
Table 1 provides descriptive information for participant demographics and Table
2 details officer-related variables. A total of 82 law enforcement officers completed the
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survey. The age of the sample ranged from 24 years to 60 years with a mean age of 40.3
years (SD = 8.73). Participants were predominately White, constituting 76.8% of the
sample, as can be seen in Table 1. The majority of the sample (79.3%) was male, which
is representative of the law enforcement profession. The majority of the sample attained a
postsecondary or college education, comprising 52.4% of the sample. The sample was
fairly evenly distributed in regard to years of experience as a law enforcement officer,
with the majority of the sample (34.1%) reporting over 20 years of service. Most
participants in the sample reported their rank as a patrol officer (62.2%). (See Table 2).
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Table 1
Demographic Variables
Variable

Total
(N = 82)
M

Age*
Gender
Male
Female
Other
Prefer Not to Say
Race/Ethnicity
White
African American
Hispanic/Latino
Asian
Other
Education
High School
Postsecondary/College
Graduate School
Years of Experience
Less than one year
1 – 2 years
3 – 5 years
6 – 10 years
11 – 15 years
16 – 20 years
Over 20 years
Rank
Patrol Officer
Sergeant
Lieutenant
Capitan or Higher
Personal/Family History of Opioid Use
Yes, Personal
Yes, Family Member
No
Prefer Not to Say
*8 participants declined to provide their age

(SD)

41.45 (8.73)
n (%)
65
7
0
10

(79.3%)
(8.5%)
(0.0%)
(12.2%)

63
0
12
0
7

(76.8%)
(0.0%)
(14.6%)
(0.0%)
(8.5%)

21
43
18

(25.6%)
(52.4%)
(22.0%)

0
2
10
14
16
12
28

(0.0%)
(2.4%)
(12.2%)
(17.1%)
(19.5%)
(14.6%)
(34.1%)

51
14
11
6

(62.2%)
(17.1%)
(13.4%)
(7.3%)

1
16
58
7

(1.2%)
(19.5%)
(70.7%)
(8.5%)
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Table 2
Officer-Related and Frequency of Contact Variables
Variable
How long agency has conducted training
0 – 2 years
2 – 5 years
More than 5 years
How frequently agency conducts training
Annually
Biannually (every two years)
More than every two years
Most recent naloxone training
0 – 2 years
2 – 5 years
More than 5 years
Length of initial naloxone training
Less than one hour – 1 hour
1 – 2 hours
2 – 3 hours
3 – 4 hours
Half – day training
Whole day training
Other
In-Service or Additional Training
Yes
No
Hours of additional training in past year**
0 – 1 hour
1 – 2 hours
3 – 4 hours
5 – 6 hours
7 – 8 hours
9 or more hours
Disparity between Fire Rescue Response
Yes
No

Total
(N = 82)
n (%)
1
11
70

(1.2%)
(13.4%)
(85.4%)

77
2
3

(93.9%)
(2.4%)
(3.7%)

79
3
0

(96.3%)
(3.7%)
(0.0%)

68
10
1
0
1
0
2

(82.9%)
(12.2%)
(1.2%)
(0.0%)
(1.2%)
(0.0%)
(2.4%)

45
37

(54.9%)
(45.1%)

17 (37.8%)
19 (42.2%)
6 (13.3%)
2 (4.4%)
0 (0.0%)
1 (2.2%)
40
42

(48.8%)
(51.2%)
**Calculated utilizing the 45 participants who endorsed receiving additional training
(Table 2
continues)
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Table 2 (cont.)
Officer-Related and Frequency of Contact Variables
Variable
How long is the disparity between Fire Rescue***
Within 2 minutes
2 to 4 minutes
5 to 7 minutes
7 to 20 minutes
Greater than 20 minutes
No disparity in response
Number of overdose calls responded to
0
1 to 2
3 to 4
More than 5
Not responded to a call for opioid overdose
Administrations of naloxone per month
0 to 1
2 to 3
4 to 5
5 or more
I have not administered Naloxone

Total
(N = 82)
n (%)
1 (2.5%)
16 (40.0%)
19 (47.5%)
4 (10.0%)
0 (0.0%)
0 (0.0%)
17
24
13
18
10

(20.7%)
(29.3%)
(15.9%)
(22.0%)
(12.2%)

43
10
2
4
23

(52.4%)
(12.2%)
(2.4%)
(4.9%)
(28.0%)

***Calculated utilizing the 40 participants who endorsed Fire Rescue/EMT disparity
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Objective 1
Objective 1 proposed assessing officer perceptions of training effectiveness with regard
to agency priority and perceived organizational support, appropriateness and relevance of
training to career, impact of training on dealing with the opioid crisis in their jurisdiction,
and stigma towards substance users. Descriptive statistics for outcome variables (i.e.,
agency priority, relevance, impact, and stigma) can be found in Table 3.
Participants were divided into groups of High or Low effectiveness (of training)
based on a median split of overall effectiveness scores (Md =16) in order to examine
effectiveness with other variables. Participants in the High effectiveness groups (n = 45)
had total effectiveness scores of >16 and those in the Low effectiveness group had total
effectiveness scores <15 (n= 37). These groups were used to assess the association
between effectiveness with other variables listed in Hypotheses 1.1 through 1.4. The
protocol was modified to remove agency information in response to low participation, as
it was suspected identifying the agency was contributing to low participation.
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Hypothesis 1.1. Officers who report their agency prioritizes naloxone training
based on officer reports of perceived agency priority of this training will perceive their
training as effective.
Responses to three individual items were scored and totaled to create an overall
agency priority score (range from 6 - 20). Participants were divided into groups of High
or Low agency priority based on a median split of the sample based on overall agency
priority scores (Md = 13). The High agency group included participants with priority
scores of >13 (n= 44) while the Low agency priority group was comprised of individuals
with total agency priority scores of <12 (n=38). High effectiveness and Low
effectiveness groups were also identified using a median split of the effectiveness scores
as previously described.
A Chi square test of independence (with Yates’ Continuity Correction) was
conducted to examine the relationship between agency priority and effectiveness ratings
(See Table 3). Results indicated that agency priority was significantly associated with
perceived training effectiveness, χ2(1) = 13.18, p < .001. Officers who reported higher
agency priority ratings were significantly more likely to perceive their training as
effective than those who reported low agency priority scores.
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Table 3
Variables and their Association with Effectiveness
Variable

High Effectiveness
(n = 45)
n (%)

Low
Effectiveness
(n = 37)
n (%)

Agency Priority
High Priority
Low Priority
Relevance to Career
High Relevance
Low Relevance

33 (40.2%)
12 (14.6%)
31 (37.8%)
14 (17.1%)

Officer Stigma1
High Stigma
Low Stigma
1

n = 44

22 (26.8%)
23 (28.0%)

27 (33.3%)
17 (21.0%)

Sig.
<.001

14.41

<.001

.00

0.98

1.35

0.16

11 (13.4%)
26 (31.7%)
9 (11.0%)
28 (34.1%)

Impact of Training
High Impact
Low Impact

Chi
Square
Value
13.l8

18 (22.0%)
19 (23.2%)

17 (21.0%)
20 (24.7%)
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Hypothesis 1.2. Officers who perceive naloxone training and administration as
effective will be more likely to agree that the naloxone program is appropriate and
relevant to their position.
Participants were categorized into groups of High or Low Career Relevance
using a median split based on overall career relevance scores (range = 4 – 15) to
differentiate the groups (Md = 11). The High Career Relevance group was composed of
participants with scores >11 (n = 57) while those in the Low Career Relevance group had
scores <10 (n = 25). High effectiveness and Low effectiveness groups were also
identified using the median of the effectiveness scores to define the groups as previously
described.
Results from chi square tests for independence (with Yates’ Continuity
Correction) showed a significant association between officer ratings of perceived
relevance of naloxone training to their careers and perceived effectiveness of their
training, χ2(1) = 14.41, p < .001,
as indicated in Table 3. Officers who reported higher career relevance were significantly
more likely to perceive their training as highly effective than those who reported low
career relevance.
Hypothesis 1.3. Naloxone trained officers who perceive naloxone training as
effective will report greater impact of their training in dealing with the opioid crisis in
their jurisdiction.
Participants who had Impact scores of 11 and above on the were categorized in
the High Impact Group (n = 50) while those with scores of <10 comprised the Low
Impact Group (n = 32). Groups were defined based on the median Impact scores of the

PERCEPTIONS OF NALOXONE TRAINING

71

sample (Md = 11, range = 6 – 15). High effectiveness and Low effectiveness groups were
also identified using the median of the effectiveness scores to define the groups as
previously described. Using the results of a chi square test of independence, no
significant association between perceived impact of training in dealing with the opioid
crisis and perceived training effectiveness was found, χ2(1) = .00, p >.05. (See Table 3).
Hypothesis 1.4. Naloxone trained officers who perceive naloxone training as
effective will report less negative stigma towards substance users.
Participants were divided into groups of High Stigma or Low Stigma based on
their overall stigma scores. Using the median of the sample stigma scores (range = 5 –
21) to discriminate the two groups (Md = 13), those with Stigma scores of >13 comprised
the High Stigma group (n = 45) and those with Stigma scores <12 (n = 37) were
categorized in the Low Stigma group. High effectiveness and Low effectiveness groups
were also identified using the median of the effectiveness scores to define the groups as
previously described. As shown in Table 3, there was no significant association between
stigma towards substance users and perceived training effectiveness, χ2(1) = 1.35, p
>.05.
An additional analysis was conducted to examine the relationship between officer
stigma toward substance use and years of experience and rank. Years of experience was
categorized into two groups: those with 16 years of service or more and those with <15
years of service. Officer rank was also categorized into two groups: those with ranks of
Lieutenant and higher and those with lower ranks. Results from the chi square tests of
independence (with Yates’ continuity correction) showed that officer stigma towards
substance users was significantly related to years of experience and rank. Officers with
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more years of service (16 years or greater) were significantly more likely to endorse
greater stigma (and more negative views) towards substance users, χ2(1) = 11.23, p
>.001. Officers of a higher rank (Lieutenant and higher) were also more likely to report
greater stigma towards substance users than officers of a lower rank, χ2(1) = 5.21, p
>.05.
An exploratory linear multiple regression was conducted to examine the ability of
overall agency priority, relevance to career, years of service, and officer rank to predict
perceived training effectiveness. Predictor variables were included if they were not
significantly related to other predictor variables to ensure the assumption of
multicollinearity was not violated. When all factors were included, the model explained
51% of the variance (R2 = .51) and the overall model was significant, F (4, 77) = 20.792,
p < .001. Only agency priority and relevance to career variables made significant unique
contributions to the prediction of effectiveness of naloxone training. Of the two variables,
relevance to career made the largest contribution (beta=.48) to perceived effectiveness. A
summary of the regression analysis can be found in Table 4.
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Table 4
Summary of Multiple Regression Analyses for Effectiveness of Training

Model 1
Effectiveness
Agency Priority
Relevance to Career
Years of Service
Rank
***p < .001

R

R2

SE of the
Estimate

0.72

.51

2.49

b (SE)

β

t

0.67 (0.14)
0.74 (0.13)
0.07 (0.22)
-0.29 (0.32)

0.41
0.48
0.03
-0.08

4.66***
5.37***
0.35
-0.89

PERCEPTIONS OF NALOXONE TRAINING

74

Objective 2
The second objective of this study was to explore the differences between officers who
received naloxone training from a law enforcement officer (LEO) and those who did not
on level of preparedness in responding to opioid related calls, attitudes towards naloxone
training and administration, effectiveness of training, and quality of training.
Preliminary review of histograms and tests of normality indicated non-normality
of the distribution of the sample data. Therefore, a nonparametric Mann-Whitney U test
was utilized to examine the relationship between officers who were trained by law
enforcement trainers and those who were not on total preparedness, attitudes towards
training, effectiveness of training, and quality of training scores.
Participants were divided into groups of Law Enforcement trained or Non-LEO
trained based on their reported trainer for the most recent naloxone training. The majority
of the overall sample reported that their training was conducted primarily by a sworn
member of their agency (n = 72), with 10 total officers indicating their received training
from Fire Rescue/EMT from their jurisdiction, Fire Rescue/EMT from another
jurisdiction, or a medical professional.
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Table 5
Summary of Mann-Whitney Analysis Between LEO-trained and Non-LEO trained
Officers on Preparedness, Attitudes Towards Naloxone Training and Administration,
Effectiveness of Training, and Quality of Training
Non-LEO
MannLEO Trained
Variable
Trained
Whitney U
z
(n = 72)
(n = 10)
Officer Preparedness
Mean
SD
Median
Attitudes re:
Naloxone Training
Mean
SD
Median
Effectiveness of
Training
Mean
SD
Median
Quality of Training
Mean
SD
Median

17.33
3.77
19.00

16.70
3.93
18.00

15.38
3.63
16.00
7.60
1.72
8.00

p.

333.500

-0.39

0.69

343.000

-0.24

0.80

345.500

-0.20

0.83

280.500

-1.14

0.25

17.80
1.87
17.50

17.00
3.88
18.00

16.00
2.53
16.00
8.20
1.54
9.00
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Hypothesis 2.1. Naloxone trained officers who receive training from a law
enforcement trainer will report a higher level of preparedness in responding to opioid
overdose calls.
Preliminary analyses indicated that assumptions of normality for the preparedness
scores were violated. As a result, a non-parametric Mann-Whitney U test was utilized.
Descriptive statistics for the scores for officer preparedness by training status can be
found in Table 5. Results from the Mann-Whitney U test showed no significant
differences in the preparedness scores between the LEO trained officers (Md = 19.00,
n=72), and the non-LEO trained officers, (Md = 17.50, n=10), U=333.500, z = -0.39, p =
0.69 .
Hypothesis 2.2. Naloxone trained officers who receive training from a law
enforcement trainer will report more positive attitudes towards naloxone training and
administration.
Preliminary analyses indicated that the assumptions for normality for the attitudes
scores for the two groups were violated. See Table 5 for the descriptive statistics of the
scores for officer attitudes towards naloxone training and administration by training
status. There was no significant difference in scores for attitudes towards naloxone
training between officers trained by LEO officers and those who were not, (Md = 17.50,
n=10), U=343.000, z = -0.24, p = 0.80.
Hypothesis 2.3. Naloxone trained officers who receive training from a law
enforcement trainer will perceive their naloxone training as more effective.
Preliminary analyses showed violations of normality of the training effectiveness
scores for the two groups. No significant differences were found in training
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effectiveness scores between officers who were LEO-trained and those were not, (Md =
17.50, n=10), U=345.500, z= -0.20, p = -0.20 , (See Table 5).
Hypothesis 2.4. Naloxone trained officers who receive training from a law
enforcement trainer will provide higher quality ratings of their training.
Preliminary analyses indicated violations of assumptions of normality for the two
groups for quality of training scores. Table 5 details the descriptive statistics for the
quality of training scores. Quality of training scores were not statistically different
between officers who were trained by LEOs and those were not trained by other officers,
(Md = 17.50, n=10), U=280.500, z = -1.14, p = -1.14.

Objective 3
The third objective of this study aimed to explore the components of naloxone
training and officer perceptions of importance to their naloxone training.
Hypothesis 3.1. The majority of naloxone trained officers will identify personal
risk and safety as the most important part of training.
The majority of officers (45.1%) identified “post-administration considerations”
as the most important component of training, followed by 18.3% of officers who
identified “signs of an opioid overdose” as the most important component of training
(See Table 6).
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Hypothesis 3.2. The majority of naloxone trained officers will identify hands-in
training activities as the most important mode of training.
To investigate this hypothesis, officers were asked to identify which was their
preferred mode of training. The majority of officers (68.3%) selected “PowerPoint
presentation by department” as their preferred mode of training, followed by 19.5% of
officers who selected “Hands-on training component” as the preferred mode of training
(See Table 6).
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Table 6
Components of Naloxone Training and Perceptions of Importance
Variable

Most important component of naloxone training
Liability and legal statutes
Info related to personal and partner safety
Signs of an opioid overdose
Opioid overdose prevalence in patrol area
Fentanyl and Fentanyl analog info
Post-admin considerations
Individual PPE kits
Impact of Narcan access and admin
Marchman and/or Baker Act
Other
Preferred mode of training
Video from pharmaceutical company
Video from department or other agency
PowerPoint presentation by department
PowerPoint presentation by external agency
Posttest
Handouts on admin and storage of naloxone
Handouts (general)
Roleplay or training scenarios
Hands-on training component
Other

Total
(N = 82)
n

%

4
10
15
0
12
37
0
0
4
0

4.9%
12.2%
18.3%
0.0%
14.6%
45.1%
0.0%
0.0%
4.9%
0.0%

1
8
56
0
0
0
0
0
16
1

1.2%
9.8%
68.3%
0.0%
0.0%
0.0%
0.0%
0.0%
19.5%
1.2%
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Chapter 7: Discussion
Impact of Study
Law enforcement officers now play an important role as medical first responders
in combating the opioid crisis. As such, it is imperative that law enforcement officers
receive adequate training related to the carrying and administration of naloxone as a
means of being appropriately prepared for this expanded role. The intention of the current
study was to provide an exploratory examination of the components of naloxone training
and administration on law enforcement officer perceptions in effectively responding to
opioid overdose calls and the opioid crisis in their jurisdiction through a transfer of
training lens.
Within the overall sample, there was limited variability regarding training
backgrounds. The majority of the sample reported attending naloxone training within the
previous year, with 93.9% of individuals indicating their department conducts annual
trainings. Almost 83% of officers indicated their initial naloxone training was less than
one hour. Of the 45 (54.9%) participants who indicated they received additional inservice training related to responding to opioid overdose calls, 37.8% reported they
received 0-1 hour of additional training and 42.2% indicated they received an additional 1
– 2 hours of training. This information, taken together with the perceived barriers, may
necessitate more frequent or periodic trainings, especially as 12.2% of officers indicated
difficulty in recognizing an overdose after receiving additional training. Ongoing training
is additionally important to address the changing nature of the opioid crisis and facilitate
awareness of new types of synthetic opioids and how to best protect officers and their
partners in responding to opioid overdose calls.
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An evaluation of how officer perceptions of agency priority and perceived
organizational support, appropriateness and relevance of training to career, impact of
training on dealing with the opioid crisis in their jurisdiction, and stigma towards
substance users impacted perceived training effectiveness yielded a number of interesting
findings across outcomes. First, the overall score for agency priority was significant in
predicting officers’ perceived effectiveness of training. Officers who perceived their
agency made naloxone training a priority were more likely to perceive their training as
highly effective. This finding is parallel to prior research conducted by Blume et al.
(2010) who found that within a transfer of training model, there is more likely to be
higher transfer of training if the agency, supervisors, and peers are perceived as
supportive of the training. When officers believe the culture of the agency is supportive
of naloxone training and administration, officer’s themselves are more likely to believe
that naloxone training is effective.
This has implications for how agency culture and perceived agency support for
the training and administration of naloxone can impact an officer’s perception of how
effective training is overall. An officer’s perception of training effectiveness may already
be impacted prior to entering the training room by the perceived positivity or negativity
related to naloxone within the agency. This suggests that if an agency overall, including
peers and supervisors, have not bought-in to the perceived benefits of carrying and
administering naloxone, the officer’s perceptions of training are likely to be negatively
impacted. This, in turn, implicates the culture of the agency in determining perceived
effectiveness of training and the degree to which an officer views the training as
successful in transferring the training objectives. Agencies must make the carrying and
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administration of naloxone a priority for the training to be perceived as effective within
their agency.
There have been several studies by Banta-Green et al. (2013), Berardi et al.
(2021), and Ray et al. (2015) that investigated officer’s perception of whether or not
carrying and administering naloxone is part of their professional role. In the current
study, officers who viewed naloxone training as relevant to their career and within the
scope of their job responsibilities were more likely to view the naloxone training as
effective. In fact, when examining which variables were the most significant in
predicting whether or not an officer viewed naloxone training as effective, relevance to
career had the largest impact. As with earlier studies conducted by Banta-Green et al.
(2013), Berardi et al. (2021), Green et al. (2013), and Ray et al. (2015), officers who
perceived carrying and administering naloxone as outside the scope of their professional
responsibilities were significantly less likely to report that the training was effective or
necessary, while officers who endorsed carrying naloxone as relevant to their career were
more likely to rate the training as effective. These findings suggest that incorporating
elements into training of how naloxone carrying and administration relates to public
safety and community policing may increase officer’s perception of the effectiveness of
the training. Training will need to clearly emphasize how and why the training is
relevant to their role as an officer in order for the training to be impactful.
This is especially important in training while navigating the changing role
expectations of law enforcement officers who are being asked to act as nontraditional
medical first responders (Donohue, 2018). One particular model in Massachusetts serves
as a template for further consideration when developing naloxone trainings and
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communicating the long-term role of law enforcement officers in the opioid epidemic. As
explained by Donohue (2018), officers have higher buy-in for naloxone programs when
there is departmental agreement that naloxone is necessary and when the long-term role
of an officer past the immediate revival of naloxone is expounded upon. Within these
programs, law enforcement officers provide public safety and assistance during the
transition between placement of individuals with substance use problems in the criminal
justice system and referrals to community-based programs. This means that officers are
gaining exposure to the impact and role of naloxone past immediate revival and can aid
in enhancing the perception of naloxone as a public safety measure. Many officers’
perspectives of naloxone administration are limited to revivals and losses, sometimes of
the same person, and in many circumstances, the same person within the same day. This
program allows officers an expanded view of how their role as medical first responders in
administering naloxone can have more long-term effects.
Additional outcomes were assessed by investigating the relationship between an
officer’s perception of the impact naloxone training has in their jurisdiction and training
effectiveness. Officers who perceived the naloxone training as having a positive impact
in their jurisdiction were not more likely to view naloxone training overall as effective.
Moreover, officer’s stigma towards substance users had no significant relationship to
perceived training effectiveness. Officer stigma towards substance users, however, was
significantly related to years of experience and rank. Officers with more years of service
(16 years or greater) were more likely to hold more negative perceptions of substance
users and endorse greater stigma towards substance users than those with less years of
service. Officers of a higher rank (Lieutenant and higher) were also more likely to report
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greater stigma towards substance users than those of lower rank. This could be due to the
greater responsibility and burden placed on higher ranking officers in managing the risks
associated with responding to opioid related calls or as a result of cynicism.
Results from this study also indicated no significant differences between groups
of participants who received training from a law enforcement officer and those who did
not across a number of measured outcomes including preparedness in relating to opioidrelated calls, attitudes toward community-based substance abuse interventions, and
effectiveness of training. These findings are not consistent with studies that have shown a
positive impact between source of training and training outcomes. This may, in part, be
due to the small number of participants who received training from a non-law
enforcement trainer (n = 10). Aguinis & Kraiger (2009) and Aragón-Sánchez et al.
(2003) described how transfer of training material is more likely to have a positive impact
if the trainer is from within the agency, though this was not observed in the current
study; however, it is important to note that of those officers who were initially trained by
a law enforcement trainer (n = 72), 22% (n = 16) reported they would have preferred to
have received training by either a medical professional or Fire Rescue/EMT. This may be
due to the fact that law enforcement officers are being asked to respond as medical first
responders and may view the content of this training to be better communicated and
transferred by a medical professional or Fire Rescue/EMT. Therefore, having a Fire
Rescue/EMT or medical professional co-trainer or primary trainer may better prepare
officers in carrying and administering naloxone.
An additional analysis exploring officer perceptions of the importance of
components of naloxone training found that the majority of officers identified “post-
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administration considerations” (verbal and physical aggression, nausea, vomiting) as
most important as opposed to “Personal and partner safety.” This finding is supportive of
the role identification officers have as securing the scene for medical professionals and
protecting Fire Rescue/EMTs while on the scene of an overdose as their primary role. In
contrast to what we had hypothesized, the majority of the officers indicated they
preferred a department PowerPoint presentation instead of Hands -On training. This may
be due to the brief nature of the trainings (i.e., majority of officers reported their naloxone
trainings lasted less than one hour) or the importance placed on what is learned through
the PowerPoint presentations (i.e., post-administration considerations, signs of an opioid
overdose, etc.). Likewise, the content associated with “post-administration
considerations” such as combating nausea) may be more deliverable via a Power Point
platform. The low number of participants who reported their department included a
hands-on training component (n = 10) is reflective of the earlier findings by Khorasheh et
al. (2019) who found many naloxone trainings failed to incorporate hands-on training
(e.g., how to assemble and administer intranasal naloxone).
As part of the study survey, officers were asked to identify limitations they
perceived to be barriers in administering naloxone. Of the officers who responded, the
reported limitations included the following: calls to respond to opioid overdose are time
consuming, a lack of continued training discomfort in responding to opioid overdose calls
and difficulty recognizing an opioid overdose. A few officers indicated the uncertainty
regarding criteria for naloxone administration presented a barrier, while only two officers
reported the availability of naloxone kits was an issue. The majority of officers who
endorsed barriers to administration noted the unpredictability of those after naloxone
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administration and lack of community resources available to refer individuals to (if not
administering naloxone) as major barriers. No officers reported the availability of a
naloxone trained officer as a present limitation.
The barriers endorsed by officers are reflective of findings in this study that noted
the most important component of naloxone training to be post-administration
considerations, such as aggression. Officers endorsed more concerns for the public safety
aspect of protecting Fire Rescue/EMTs, securing the scene, and ensuring the safety of
others due to the volatility of individuals post-naloxone administration. Many individuals
who have overdosed and been successfully revived with opioids may become nauseous or
experience symptoms of acute withdrawal, while few become combative (Buajordet et
al., 2004; Fisher et al., 2016). Moreover, officers also reported the lack of available
community resources for referral of individuals post-overdose for opioid treatment. This
mirrors earlier research presented by Gatewood et al. (2016) detailing the medical
community’s concern of naloxone being utilized as emergency medical intervention,
without treating the root cause of addiction. Both of these perceived limitations and
barriers to administration of naloxone contribute to the qualitative responses provided by
officers discussed in the following paragraph.
A qualitative component was added to this study to allow for further commentary
from officers related to memorable issues and aspects in responding to opioid overdose
calls. In reviewing the comments provided, many officers indicated having positive
experiences of saving lives while utilizing Narcan. Some also commented on the wish
that Narcan was available to them earlier in their career when they were on patrol. One
individual provided a particularly unique narrative in describing specific aspects of
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administering Narcan that are of importance to how departments approach officers’ postadministration:
“Performing CPR on the floor of a fast-food restaurant bathroom after a first
failed Narcan administration attempt (2nd one worked), is something that will
forever be embedded in my memory. There is no mental health care for incidents
as such. It's like overdose calls are "any other call" to law enforcement agencies.
In my opinion, they're still traumatic to respond to.”
While the focus of this study was primarily on naloxone training, this respondent has
identified an area for further study. How do departments manage incidents wherein
officers administer naloxone and save a life? Is the emphasis on officer mental health
placed primarily on addressing failed attempts at administering naloxone and should a
greater emphasis be placed on the entire experience as a medical first responder which is
an expanded role for officers?
Additional commentary highlighted the frustration felt among participants at the
readily available naloxone in their communities. The majority of this frustration was due
to multiple administrations of naloxone for the same person, continued use of opioids
after a successful revival using naloxone, and the “ungratefulness” and hostility officers
experience after reviving someone with naloxone only to be told they “ruined their high.”
Much of this commentary demonstrates the overwhelming nature of addiction and
potential lack of community-based substance use treatment, as mentioned by some
officers, to successfully divert future and continued opioid use. This was additionally
reflected in earlier discussions of officer’s perceived barriers and limitations related to
naloxone administration. One officer commented:
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“As a member assigned to a behavioral health team, overdose response/follow up
is a primary function of daily assignment. The largest issue is buy-in from the
subject after an overdose in understanding the necessity for treatment from mental
health providers to combat addiction.”
This highlights the need for follow up and continued care after harm-reduction
interventions, such as naloxone, for officer actions in combating the opioid crisis to have
a wider impact. These comments also provide some insight into the potential negative
perceptions of substance users and naloxone training and administration expressed by
some officers in the survey.
Several of the officers who provided responses also indicated they had
administered naloxone and experienced post-administration combativeness from
individuals. This is interesting as several sources reported that few individuals become
aggressive after naloxone revival, though the officers in the survey reported contrary
findings. If officers in this sample experienced higher than average instances of
aggressiveness after overdose reversal with naloxone, the importance of education related
to post-administration considerations would be greater than average as well. Full
commentary and responses can be viewed in Appendix C.
Conclusions. This study was the first to examine naloxone training through a
transfer of training lens to determine if it is culturally appropriate for law enforcement.
While the idea that the trainer would have a significant impact on training outcomes was
not supported, it did highlight an important shift in the number of officers who were
trained by a law enforcement officer but preferred to be trained by a medical professional
or Fire Rescue/EMT. This suggests that with the shifting and expanding role of law
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enforcement acting as medical first responders, officers recognize a need for additional
training or support from the medical community. As such, agencies might consider
incorporating Fire Rescue/EMT or medical personnel into their trainings as co-trainers or
primary trainers to address the medical components related to opioid overdose and
naloxone administration.
Agency priority and relevance to career were identified as significant predictors
perceived effectiveness of naloxone training. This suggests that the importance placed on
enhancing the visibility of agency priority to all ranks of officers can have a positive
impact in how officers perceive the training. Many officers who reported the agency or
agency culture was not supportive of the training indicated a lack of training efficacy.
Shifting the overall agency culture to prioritize naloxone training and administration at
the command level can filter down and impact the patrol level to adjust officer perception
of naloxone training. Moreover, officers who perceived the training of carrying and
administering naloxone as more relevant to their career were more likely to view their
training as more effective. This finding is relevant because it highlights the officers who
accept and incorporate the shifting role to medical first responder into their current role
and the willingness to adapt to the changing landscape of public safety and the opioid
crisis. In light of this finding, it is important for departments to effectively communicate
during trainings how the expanded role expectations of naloxone administration is
relevant to their career as a law enforcement officer and public safety agent. Part of this
shift may include the similarities between harm reduction strategies, like naloxone, and
community policing, both of which offer a proactive approach to combating long-
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standing community issues. This study opens the door to evaluate the most effective
means of training officers to carry and administer naloxone.
Limitations and Directions for Future Research
There exists a wealth of information to date demonstrating the efficacy of
community policing and harm reduction policies across the nation for dealing with the
opioid crisis in community settings; however, naloxone training is a relatively new
expansion for law enforcement as a means of reducing opioid-overdoses. There were
several limitations to this study, one being that the majority of participants were from the
state of Florida. Florida has a significant role in the history of the opioid epidemic and
with the introduction of the “pill mills” and Florida law enforcement agencies have been
on the frontlines of battling opioid overdoses since the declaration of the national public
health crisis. They are a well suited and experienced sample to respond to the perceptions
of naloxone training in general, and to speak to the factors that enhance effectiveness of
training. This does not go without acknowledgement that the opioid epidemic has
permeated other states, specifically West Virginia, North Carolina, and Massachusetts.
Each of these states has begun to independently collect data on the relationship between
the implementation of naloxone training and the impact on opioid overdoses in their
communities. Findings from this study, therefore, will have limited generalizability to
officers employed outside of state law enforcement agencies and serving outside of
Florida.
Another limitation of this study was the inability to determine how prior naloxone
training at a department or with another department effects the outcome or attitudes of an
officer. This study focused on the most recent training experience. This did not account
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for officers who may have transferred departments, completed a different departmental
training, completed outside training prior to hire, or completed a separate training prior to
implementation of a new training. Therefore, the cumulative effects of training
experiences were not assessed in the current study. Lastly, the survey was offered on a
voluntary basis such that officers who choose to participate could introduce a sampling
bias. In addition, the primary outcomes in this study were assessed by self-report which
may be vulnerable to participant response bias. Although officers were assured that their
responses would be anonymous and confidential, they may have chosen to limit their
disclosure, or bias their reporting on the survey to minimize negative perceptions of their
agencies.
Future surveys may include a measure of officer cynicism to compare to training
effectiveness. This study did not attempt to identify how cynicism may impact officer’s
perception of training and the interaction between cynicism and stigma. Additionally,
future surveys might explore pre- and post- test attitudes towards training, officer stigma,
and officer cynicism in relation to law enforcement trainers and Fire Rescue/ EMT
trainers. It is also imperative that a larger sample size and more diverse geographical
distribution be considered when conducting future research.
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Appendix A
Informed Consent
Please read this consent document carefully before you decide to participate in this study. The
researcher will answer any questions before you sign this form.
Purpose: This research study is being conducted by Katelyn Goodall, a clinical psychology doctoral
student, under the supervision of Dr. Vida Tyc at Florida Institute of Technology. You are asked to
participate in this study that examines Naloxone training components across departments in the state of
Florida. Your data will be compared to data of other law enforcement agency employees obtained as part of
this study.
What You Will Do: Upon agreeing to participate, you will be asked to provide some general demographic
information about yourself. Next, you will be asked to complete the Survey of Opioid Overdose Training
Available to Law Enforcement Officers Completing Naloxone Administration, a self-report questionnaire.
This questionnaire takes approximately 10-15 minutes to complete.
Potential Risks and Voluntary Participation: The potential risks anticipated with participating in this
study are minimal and unlikely. While completion of the self-report questionnaire is not expected to cause
any harm or discomfort, you have the right to withdraw from the study at any time without consequence.
Your participation in this study is completely voluntary, and there is no penalty for not participating.
Benefits of Participating: Your participation in this study will provide information contributing to the
knowledge of best practices in training law enforcement agency employees in relation to opioid overdose
and Naloxone policies that will ultimately provide a better understanding of best practices for transfer of
training.
Confidentiality: To ensure your anonymity and confidentiality of your identity, your response records and
data sources will be assigned a participant identification number, instead of any personal identifying
information. All data and findings will be tied to this participant identification number only, and your name
will not be used in any part of this study. This consent form, which requires your signature, will be stored
separately from all data sources to ensure confidentiality.
How Data Will Be Used: The results of this study will be used for scholarly research purposes only.
Participants will not receive individual feedback regarding their test results and participant test results will
not be disclosed to anyone else.
Contact Information: If you have any questions or concerns about this study, please contact Katelyn
Goodall at kgoodall2018@my.fit.edu or Dr. Vida Tyc at vtyc@fit.edu. You may also reach out to Florida
Tech’s IRB Chairperson, Dr. Jignya Patel, with any concerns about this study.
Dr. Jignya Patel, IRB Chairperson
150 West University Blvd.
Melbourne, FL 32901
Email: FIT_IRB@fit.edu Phone: 321.674.8104

Agreement:
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By signing below, I am affirming that I have read the procedure described above, I voluntarily agree to
participate in the procedure, and I have received a copy of this description. I also am affirming that I am
18+ years of age.
Participant: ___________________________________________ Date: _________________
Principal Investigator: ___________________________________ Date: _________________

PERCEPTIONS OF NALOXONE TRAINING

111

Appendix B
Survey of Opioid Overdose Training Available to Law Enforcement Officers
Completing Naloxone Administration
Part A:
1. Have you completed your department's Naloxone (Narcan/Evzio) training?

☐ Yes

☐ No

2.a. Who conducted your most recent Naloxone training (select all that apply)?
◻Sworn member of my agency
◻Non-sworn member of my agency
◻Sworn member of another law enforcement agency
◻Retired sworn officer from my agency
◻Retired sworn officer from another agency
◻Fire/Rescue/EMT from my jurisdiction
◻Fire/Rescue/EMT from another jurisdiction
◻Medical Professional
◻Consultant/Training Vendor
◻Other:_______________________________
2.b. Who would you have preferred to conduct your Naloxone training?
◻Sworn member of my agency
◻Non-sworn member of my agency
◻Sworn member of another law enforcement agency
◻Retired sworn officer from my agency
◻Retired sworn officer from another agency
◻Fire/Rescue/EMT from my jurisdiction
◻Fire/Rescue/EMT from another jurisdiction
◻Medical Professional
◻Consultant/Training Vendor
◻Other:_______________________________
(Objective 1.3; Objective 2.1, 2.2)
3. How long has your agency conducted trainings on naloxone administration? (Objective 1.1)
☐ 0-2 years ☐ 2-5 years ☐ More than 5 years
3.a. How frequently does your agency conduct naloxone trainings?
☐ Annually ☐ Biannually (every two years) ☐ More than every two years
4. How long ago were you most recently trained to administer naloxone? (Objective 1.1)
☐ 0-2 years ☐ 2-5 years ☐ More than 5 years
5. How long was your initial training:
◻Less than one hour - 1 hour ◻1 - 2 hours
◻Half-day training ◻Whole day training

◻2-3 hours
◻3-4 hours
◻Other: __________________________

6. a. Please select components included in your most recent naloxone training: (select all that apply):
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◻Liability and legal statutes
◻Information related to personal and partner officer (and K9) risk and safety
◻Signs of an opioid overdose
◻Opioid overdose prevalence in your patrol area
◻Fentanyl and Fentanyl analog information
◻Post-administration considerations (use of force, combativeness)
◻Individual PPE kits
◻Impact of Narcan access and administration on the opioid crisis
◻Marchman and/or Baker Act
◻Other:___________________________

6. b. Please select the mode of delivery of your most recent naloxone training (select all that
apply):
◻ Video from pharmaceutical company
◻Video from your department or other local agency
◻PowerPoint Presentation by department
◻PowerPoint Presentation by external agency
◻Posttest
◻Handouts on administration and storage of naloxone
◻Handouts, other (general information covered in training)
◻Roleplay or training scenarios
◻Hands-on training component (i.e., how to administer naloxone)
◻Other:_____________________________
7. Please select the preferred mode of delivery of naloxone training (select all that apply):
◻ Video from pharmaceutical company
◻Video from your department or other local agency
◻PowerPoint Presentation by department
◻PowerPoint Presentation by external agency
◻Posttest
◻Handouts on administration and storage of naloxone
◻Handouts, other (general information covered in training)
◻Roleplay or training scenarios
◻Hands-on training component (i.e., how to administer naloxone)
◻Other:_____________________________
8. Do you believe Naloxone training was beneficial for your career/experiences? (1.2) ☐ Yes ☐ No
9. Have you received any in-service or additional training in responding to opioid overdose calls
(excluding initial naloxone training)? (1.1)
☐ Yes ☐ No
10. If yes, how many hours of training in responding to opioid overdose calls do you estimate you
received in the past year (excluding initial Naloxone training)?
☐ 0-1 hour
☐ 1-2 hours
☐ 3-4 hours
☐ 5-6 hours
☐ 7-8 hours
☐ 9 or more hours
11. Is there a disparity between fire rescue and law enforcement response times regarding opioid
overdose in your jurisdiction? ☐ Yes ☐ No
If yes:
☐ within 2 minutes ☐ 2 to 4 minutes ☐ 5 to 7 minutes ☐ 7 to 20 minutes ☐ greater than 20
minutes
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☐ No disparity in response time
12. How many calls for service involving an opioid overdose do you estimate you respond to per
month?
☐ 0 ☐ 1 to 2
☐ 3 to 4
☐ More than 5 ☐ I have not responded to a call for an opioid
overdose
13. How many administrations of naloxone do you estimate you initiate per month?
☐ 0 to 1
☐ 2 to 3
☐ 4 to 5
☐ 5 or more
☐I have not administered Narcan
Part B:
Please rate your level of agreement with the following statements:
1 Strongly Disagree 2 Somewhat Disagree 3 Neither Agree nor Disagree 4 Somewhat Agree 5
Strongly Agree
14. The naloxone training content met my expectations. (2.4)
1
2
3

4

5

15. Opioid overdose training, including naloxone training, is of great relevance to my career as a law
enforcement officer. (1.2)
1
2
3
4
5
16. Opioid overdose training, including naloxone training, is effective by positively impacting how
officers handle calls involving opioid overdose. (1.2)
1
2
3
4
5
17. Opioid overdose training should be required of all law enforcement officers. (1.2)
1
2
3
4

5

18. My department provides a sufficient amount of training to effectively respond to opioid overdose
calls. (1.1/2.3)
1
2
3
4
5
19. My department has clear policies and procedures to respond to persons overdosing on opioids (i.e.,
clarification on Good Samaritan Act, Naloxone Administration). (1.1)
1
2
3
4
5
20. My department promotes Naloxone training for officers. (1.1)
1
2
3

4

5

21. I feel knowledgeable in identifying an opioid overdose. (Objective 1.1; 2.1)
1
2
3
4

5

22. I feel prepared to respond to calls involving individuals overdosing on opioids. (2.1)
1
2
3
4

5

23. I feel comfortable interacting with individuals with opioid addiction. (2.1)
1
2
3
4

5
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24. I encounter “frequent fliers” in my work as a law enforcement officer (i.e., individuals known to
law enforcement to have an opioid addiction and often require intervention). (1.4)
1
2
3
4
5
25. There should be a limit on how often someone who overdoses on drugs is administered naloxone.
(Objective 1.3/2.2)
1
2
3
4
5
26. People who overdose need to be arrested or charged. (1.4)
1
2
3

4

5

27. The substance abuse treatment system works effectively to treat opioid addiction. (1.3/2.2)
1
2
3
4

5

28. Law enforcement officers play an important role in addressing the opioid crisis. (1.2)
1
2
3
4

5

29. Law enforcement officers are making a positive impact in addressing the opioid crisis. (1.3)
1
2
3
4

5

30. COVID-19 has had a direct impact on my interactions with individuals overdosing on opioids.
1
2
3
4

5

31. The frequency of opioid overdose in my jurisdiction is a major community issue. (1.3)
1
2
3
4

5

32. Increasing access and utilization of naloxone is a good response to the current opioid problem.
(1.3)
1
2
3
4

5

33. My department’s naloxone training adequately prepared me to administer naloxone. (2.1)
1
2
3
4

5

34. Naloxone training is a good use of the department’s resources and funding. (1.1/2.3)
1
2
3
4

5

35. Increasing access and utilization of naloxone provides individuals with a substance use disorder an
excuse to continue their drug use. (1.4)
1
2
3
4
5
36. Administration of naloxone is not worth the professional liability to me as an officer. (1.2)
1
2
3
4

5

37. It should not be the job of law enforcement to respond to drug overdoses. (1.2)
1
2
3
4

5

38. People who are arrested or charged after an overdose will be motivated to stop using opioids. (1.4)
1
2
3
4
5
39. Opioid users will be less likely to seek out treatment if they have access to naloxone. (1.3)
1
2
3
4

5
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40. Officers should carry naloxone in case I, or another officer/K-9, is accidentally exposed to an
opioid. (1.2/2.2)
1
2
3
4

5

41. My peers and supervisors are supportive of my department’s naloxone policies. (Priority
Outcome)
1
2
3
4

5

42. Please rate the quality of the most recent naloxone training you received: (2.4)
1
2
3
4

5

Very Poor

Poor
Excellent

Neutral

Good

43. Please rate the priority this agency places on naloxone training: (Priority Outcome)
1
2
3
4
Very Low
High

Low

Neutral

High

5
Very

Please check all of the following you consider limitations in responding to opioid overdose calls for
service.
☐ Calls are time-consuming for the officer
☐ Lack of continued training related to opioid
overdose
☐ Discomfort responding to opioid overdose calls
☐ Difficulty recognizing an opioid
overdose
☐ Uncertainty regarding criteria for Naloxone administration ☐ Availability of Naloxone kits
☐ Availability of Naloxone trained officers
☐ Unpredictability of those after Naloxone
administration
☐ Lack of community resources available to refer individuals to (if not administering Naloxone/calling
EMS)
☐ Other: _____________________________________________________
What has been the most memorable issue or aspect related to your role as a law enforcement officer
responding to opioid overdose calls in your patrol area?
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Demographic Information
Please choose which of the following describes you best:
Gender: ☐ Male
☐ Female
☐ Other
☐ Prefer Not to Say
Age: _________
Race/Ethnicity: ☐ White ☐ African American ☐ Hispanic/Latino ☐ Asian ☐ Other
Educational achievement: ☐ High School
☐ Postsecondary/College ☐ Graduate school
Years of experience as a law enforcement officer: ☐ less than one year
☐ 1-2 years ☐ 3-5 years ☐ 6-10 years ☐ 11-15 years ☐ 16-20 years ☐ Over 20 years
Rank: ☐ Patrol officer
☐ Sergeant
☐ Lieutenant
☐ Captain or higher
Have you had any personal experiences with opioid abuse and/or received opioid abuse
treatment OR opioid overdose?
☐ Yes, personal
☐ Yes, family member
☐ No
☐ Prefer Not to Say
Agency name (all surveys are anonymous; please do NOT provide your personal name or identifying
information, only your agency name): _________________________________________________
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Appendix C
What has been the most memorable issue or aspect related to your role as a law
enforcement officer responding to opioid overdose calls in your patrol area?

saving a life
The sheer prevalence of fentanyl and related opioids has made it very hard for law enforcement
in my community. There are many overdoses and overdose deaths each day. Many victims are
not affected by the naloxone until they are administered several doses due to overdosing so
frequently.
it feels good to not watch someone die
Once the subject is given NARCAN and a Marchman Act is invoked they can walk away once
medically cleared. There needs to be tougher consequences for Opioid use.
The administration of NARCAN encourages those with addiction to continue in the addiction
and avoid treatement/recovery, 100%
All of the "drug dealers" we encounter that sell/distribute heroin are always in possession of
Narcan, and many of the users now have a Narcan on their person upon encounter/arrest. The
most memorable moment was arresting a female who advised her boyfriend had died the week
prior, and complained "why didn't anyone just give him Narcan so he would still be alive
today". The effectiveness of Narcan is absolutely amazing, however on the streets it is now
another tool for users to carry as an 'excuse' to keep using, and a tool for dealers to carry to
make sure their buyers stay alive to continue purchasing heroin from them.
As a member assigned to a behavioral health team, overdose response/followup is a primary
function of daily assignment. The largest issue is buy-in from the subject after an overdose in
understanding the necessity for treatment from mental health providers to combat addiction.
Getting Narcan refilled
Being able to save someone's life and provide a choice to enter rehab
Postive- Many stories of deputies saving lives using narcan.
The number of people who have multiple ODs (e.g. Mike, who has been NARCANed 10
times).
Narcotic users continue to use and overdose knowing law enforcement will respond and
administer Narcan.
Help saved a couple lives using Narcan.
Time sensitive response is crucial
Going to the same house multiple times for different siblings overdosing. The mother did not
know what resources she could utilize.
Performing CPR on the floor of a fast food restaurant bathroom after a first failed Narcan
administration attempt (2nd one worked), is something that will forever be imbedded in my
memory. There is no mental health care for incidents as such. It's like overdose calls are "any
other call" to law enforcement agencies. In my opinion, they're still traumatic to respond to.
Administering doses to the same people.
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Saving the life of an individual who overdosed giving them an opportunity to get into a
treatment plan.
Responded to a male who overdosed. Administered Narcan and he was transported to a
hospital. Resources had to be taken from public services (Sheriff's Office, Fire Rescue) as well
as doctors and nurses at the hospital to care for the male. The male has overdosed several more
times afterwards.
saving lifes
I’m a detective. It’s been years since I responded to a OD unless it was a death. We didn’t have
Narcan when I was on the road
I've responded as a detective to overdose calls. Usually, the victim/patient is deceased or near
deceased. I believe education would be more effective than responding to victim's who ingest
illegal substances. Also, higher or stiffer penalties for those who sell or distribute should be
considered.
I had the same person overdose twice in one shift due to the availability of Naloxone to them.
Providing someone who is overdosing Naloxone and saving their life. Then submitting them
into the hospital under Marchman Act, only to see them using opioids again later that same
shift.
USING IT AND NOTHING HAPPENS. FD ARRIVES ON THE SCENE USES THEIR
NARCAN AND THE PERSON COMES OUT OF IT. FD TELLING ME THE NARCAN
THEY ISSUE LEOs ARE PRETTY MUCH WATER.
Convincing a subject who had no pulse prior to being administered Narcan that she needed to
go to the hospital and was still in danger. She was combative when she first recovered.
Having the "victim" yell at you because you ruined their High.
The ungratefulness of the people who have received naloxone. They continue their behavior
and are upset we ruined their high.
Everyone that I have administered have all wanted to fight
Arresting the subject who overdosed and he acted like he was appalled that he be taken to jail
for having heroin in his possession. It’s like they believe that overdosing is a get out of jail free
card.
Sometimes the subjects throw up or are freaked out when they wake up. Sometimes they get
aggressive. Even at the brink of death, some users will continue to use again.
I have grown to known families in my community who struggle with the loved ones opioid
addiction. I have gone through similar things in my own family, so being able to comfort them
from a perspective of experience helps them. I see the family members all over my community
and we are always happy to see each other.
How people who receive and positively respond to being administered Narcan can be in
complete denial of opioid use.
Utilizing Narcan on an individual two different times during a twelve hour period on two
separate overdose calls. Same individual was saved, with Narcan, from another overdose
approximately 3 months prior.
Obtaining and issuing naloxone to the agency.
Drivers who have overdosed and continue to drive on the roads while under the influence.
Subjects who overdose see the administering on Naloxone as a way to keep using drugs
because if they do overdose they'll be brought back from the overdose by it.
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The fact we will save someone 2-3 times and then they OD outside the jurisdiction.
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